White Cell Disorders i
-
Upload
evan-jane-gacott -
Category
Documents
-
view
217 -
download
0
Transcript of White Cell Disorders i
-
7/24/2019 White Cell Disorders i
1/105
WHITE CELL DISORDERS I & II
Title: White Cell Disorders I & II
Date & Time: Monday, November 12, 2012 at 12 nooon (White Cell Disorers I)
Date & Time: Wednesday, November 1, 2012 at 12 nooon (White Cell Disorers
II)
!e"t#rer: The $atholo%y Team
QUIZBANK -- Blood & Lymph #'s 133-139, 178-333
INTROU!TION
"o $%ll ( )o )h%s m*)%*l +y )%m yo (l * l* lymph od ospl, o h*+ * p*)%) $%)h * *.om*l !B!/
0Lm%*s *d lymphom*s0 %s )h mos) d%((%2l) %) % d%2*l
4*)holoy 52p) (o loml* d%s*s/ "o 2*') l* %) %( yo * o)2o)%*lly *s% yosl(, 06hy0
"o * *l*dy (*m%l%* $%)h )h d+lopm) o( )h d%(() %ds o($h%) 2lls, *d )h lo2*)%os o( lympho%d )%ss )hoho) )h .odylymph ods, 6*ldy's %, 4y's p*)2hs, spl, l* *%$*ys/
T-2ll :os; )hyms, lymph od p**(oll%2l* 2o)5, spl%2$h%) plp * *)%ol
B-2ll :os; m%*l 2)s *d )h% m*)ls, spl%2 $h%)plp *) %)s m*%s
Amo 2%2l*)% lympho2y)s, 8
-
7/24/2019 White Cell Disorders i
2/105
I d%s2ss% d%s*ss )h*) *((2) m.s o( $h%) .lood 2lls % )hp%ph*l .lood, %) %s m2h mo s(l )o )*l *.o) AB@OLUT !LL!OUNT@ )h* 0p2)* 2o)s0/
O( 2os, yo 2* s)%m*) )h *.sol) 2o) .y ml)%ply% )h
)o)*l 6B! 2o) 5 )h = (o * p*)%2l* 2ll/
*l)hy *.sol) 2o)s;
B*soph%ls; ? ($- 1
-
7/24/2019 White Cell Disorders i
3/105
A ood 0om*l *0 (o )o)*l $h%) 2o) %s D
-
7/24/2019 White Cell Disorders i
4/105
!3, !D, !8, PT2R, T2R, T2R, ST!R, o)hs; )h mom*) T-2lls +*%os %ds
!1* T; som T-2lls, *ll L*h*s m*2oph*s
!E; m*)l 2ll lymphom*, m*y !LL
? !1< !ALLA; mos) B-2lls m*)l 2ll lymphom* %s *)%+
!1E; os) Rd-@). 2llsF som o)hs
? !19; B-2lls, .) o) pl*sm* 2lls
? !>>; mos) B-2lls B 2p)o
? !3D ; p%m%)%+ .lood 2lls -- *) (o 2o)% 0.l*s)s0 %lm%* C plm%*
!DE 02ommo lo2y) *)%0 C L!A; *ll $h%) 2lls? 52p)%o; Rd @). 2lls *d som lm%*s
? !E; os) 2os%s)) m* (o )h *)*l-%ll lympho2y)s,o-B, o-T 2lls m*% p m*y. 1; 1D>E, >
-
7/24/2019 White Cell Disorders i
5/105
* 2lo*l I !lo*l%)y (o B-2lls, T2R-*mm* !lo*l%)y (o T-2lls/
2y2l% 1; m*)l 2ll lymphom* s)*%s s)oly
2y)opl*sm%2 I; pl*sm* 2lls
? osp2%(%2 s)*s; moo2y)s
M2 2p)o; B-2lls, moo2y)s
TRA4; h*%y-2ll lm%*
LA-CR CI*; L*h*s 2lls *d o)h *)%-ps)%m*2oph*sF som o)h 2lls
lyso:ym; moo2y)s
? *lph*1-*)%2hymo)yps%; moo2y)s
y)hoph*o2y)os%s; moo2y)s
mylo-po5%d*s; *lo2y)s
? @d* .l*2; *lo2y)s
? 2hloo*2)*) s)*s; )oph%ls, .*soph%ls, m*s) 2lls
pl*)l) m*s; m**yo2y)s
? 4A@ d%((sly; y)ho2y)s, m**yo2y)sCpl*)l)s
? 4A@ 2hs 0.lo2s0; %mm*) lympho2y)s o lm%*
@-1
-
7/24/2019 White Cell Disorders i
6/105
? Th h*s . )*l o( d%*os% *d 2l*ss%(y% lymphom*s.*sd o l%))l .%ops%s lss %+*s%+ )h* )*% o) * $hollymph od/ As yo'd 5p2), lss )h's * *sy )*dm*(%d% o )$o m*)l-2ll lymphom*, T-lympho.l*s)%2 lymphom*,%) 2*') . do l%*.ly Am/ / !l%/ 4*)h/ 1>8; D7D, >
-
7/24/2019 White Cell Disorders i
7/105
@p*2-o22py% ls%os 0myloph)h%s%2 *m%*s0
@ol%d 2*2s
*lom*s
m*)olo%2 m*l%*2%s )h*) sppss*lopo%s%s %//, som lm%*s *d lymphom*s
NA po.lms
!*2 2hmo)h*py
R*d%*)%o s%2ss
0Th m*lo.l*s)%2 *m%*s0
d%)*y 2y2l%2 J/ 3 $/, s+F dom%*) m)*)%os*lly % )h LA> l*s)*s , mol2l* .%oloyBlood 9>; >>9, 1998F o 2*s %s m)*)d)oph%l l*s)*s )h*) %)sl( d*m*s )h 2lll*m*2h%yF *lso N*)/ )/ 3E; 9
-
7/24/2019 White Cell Disorders i
8/105
s)*/ Th s*l 2*s o( +y lo$ *.sol))oph%l 2o) *) .%)h *d *()/
Id%op*)h%2
? Th l*. m*2h% d%d') 2o) )hm/
Th .lood s*) % TA )oo lo *d )h)oph%ls s)2 )o)h/
Th p*)%) h*s o o( lm%*s Cplm%*s % $h%2h )h )oph%ls do')m* m2h mylopo5%d*s, *d )h m*2h%sd )h mylopo5%d*s *2)%o )o 2o))oph%ls
!@@ @TRU!TION OM NUTRO4IL@
A)o%mm *, )h% o( lps
ypspl%sm s .lo$
@Js)*)%o % * *p%dly-o$% *.s2ss
Id%op*)h%2
RU@; Th m2h*%sms * )yp%2*lly o.s2 A/ I)/d/ 1D; E7, >
-
7/24/2019 White Cell Disorders i
9/105
d*pso
d%pyo
m)h%m*:ol
po2*%*m%d
popyl)h%o*2%l
%)5%m*.
sl(*s*l*:%
)%2lop%d%
4R@ONAL-TRIIAL
@om popl o( A(%2* ds2) popl Vs) h*+
sl%h)ly lo$ )oph%l 2o)s
@om $om ) * m%ld )op%* *od )h%p%ods
ARANULO!"TO@I@ %s * )%m-hood m%som (o)op%* s((%2%)ly s+ )o p) * pso *) %s (o s%os
-
7/24/2019 White Cell Disorders i
10/105
%(2)%o %//, )oph%l 2o)s o( 1
-
7/24/2019 White Cell Disorders i
11/105
o $%dsp*d )%ss 2os%s (om *y 2*s
do') (o) sy *d myo2*d%*l %(*2)s
o l*) p*2y 2ommo, m%ld
o *lly .*d 02oll*-+*s2l* d%s*s0
o Vs) pl*% 0s)ss0, *s*, *dCo phys%2*l p*% -m*%*)s)oph%ls
l2o2o)%2o%ds *d p%ph% do )h s*m )h%F
l2o2o)%2o%ds *lso p+) )oph%ls (om )%)%sss
NOT; Typho%d p*)%)s *d som sp-sp)%2 p*)%)s m*y.2om )op%2 .2*s *lopo%s%s %s sppssd*dCo *ll )h )oph%ls h*+ m%*)d (om )h .lood/ B$*o( ly% o $h%) 2o) *s yo 2h%( m* (o %(2)%o
NOT; Th sp-s%2, sp)%2 p*)%) %s l%ly )o h*+ TOI!RANULATION 5)*-pom%) *:oph%l%2 *ls,!"TO4LA@I! A!UOL@ 0(om do% *ll )h*) ph*o2y)os%s0,*dCo OL BOI@ oh dopl*sm%2 )%2lm m*)s/
By 2o)*s), %( )h )oph%l 2o) s%mply %ss (om *2) p*%*d 0s)ss0, )h $%ll . o )o5%2 *l*)%o, +*2ol%:*)%o, ol() sh%()/ o *.o) )hs % 0!l%%2*l 4*)holoy0/
{13646}ohl .ody{13661}ohl .ody{16213}ohl .ody
? M) p*)holo%s)s; Th l*)) )$o 0ohl .od%s0 *(*sF )hy * (om 2*ss o( *y-l%'s s*y 0h-
A"-l0 sm%-d%s*s, * *)osom*l dom%*) )*%) $%)h)oo-($, )oo-.% pl*)l)s *d lo)s o( 0ohl .od%s0 *d .%*lsF )h )oph%ls (2)%o om*lly/ *y-l%0ohl .od%s0 * *2)*lly o-ms2l myos% A, m)*)d % *y-l%; N*)/ )/ >; 1
-
7/24/2019 White Cell Disorders i
12/105
NOT; LMT @IMT (s )o ps2 o( %mm*) $h%) 2lls0.*ds0 % )h p%ph*l .lood, %//, )hy' .% mo.%l%:d*ly (om )h .o m*o$/ To )ll * 5)m 2*s 6B!Gp )o1
-
7/24/2019 White Cell Disorders i
13/105
DED, >
-
7/24/2019 White Cell Disorders i
14/105
+%s2*l l*+* m%*s do *d 2*) od$oms
2)*os l*+* m%*s do *d 2*) hoo$oms
*lly mos) *yF .) o)o%osly old )h*py (o *)h%)%s, $h
os%oph%l%* %s *lmos) 5p2)d
od%'s d%s*s * l* m%o%)y o( 2*ss
!h-@)*ss * +*s2l%)%s, o() $%)h *lom*s, s*lly $%)h AN!AF%)'s o) 2l* $h)h )h%s %s * sp**) d%s*s, o s%mply )h $*y6's C poly*)%)%s m*%(s)s % (ols $%)h *ll%s
m*)%)%s hp)%(om%s
M*m%l%*l hypos%oph%l%* lo2s o$, *)osom*l dom%*), m%ld;Blood 1
-
7/24/2019 White Cell Disorders i
15/105
? m*s)o2y)os%s $%)h os%oph%l%* mol2l* s%*) o$, spos)o %m*)%%.Cl+%2 l%ly
? T-2ll opl*sms m*% %)l%-E; N 3D1; 11D1, 1999
? 0!lo*l os%oph%l%*0 -- MI41L1-4MRA (s%o
? os%oph%l%2 lm%* -- loos l% !L $%)ho) poo( o( 2lo*l%)y
NOT; I )h d+lopd $old, *mo 2l%%2*lly h*l)hy p*)%)s $%)h%sol*)d l+*)d os%oph%l 2o)s, yo $%ll o() o) (%d )h 2*s/
NOT; I d%d !B!'s (o y*s o md%2*l s)d)s, m*y o( $hom h*+h*y (+, )2/, *d h*+ + (od o $%)h * l+*)d os%oph%l2o)/
NOT; Rmm. )h*) os%oph%l%2 2o)s * p % )h *()oo *ddo$ % )h mo% .2*s )h mo%'s 2o)%sol s sppsss)hmF I'd ss) )*% * s%os loo *) * *.sol) os%oph%l 2o)o+ 3E< o so % )h mo%, *d o+ E< % )h *()oo/
NOT; Th 0Lo((l's os%oph%l%20 po.lms * * 2%os, m%5d-.*o( d%s*ss $%)h 52ss%+ m.s o( os%oph%ls % +*%os )%sss)h*) 2*s )%ss d*m*/
Th mos) 2ommo (om %s po.*.ly 2*sd .y * .% opl*smo( som so), h%dd som$h, $%)h * (s%o 2*lldMI41L1-4MRA !*2 11
-
7/24/2019 White Cell Disorders i
16/105
{14099}os%oph%l%2 lo2y)s .((y 2o*){09207}os%oph%l *l $%)h 2ys)*l l2)o m%2o*phsF )hs 2ys)*ls$%ll 2om.% )o (om l* !h*2o)-Lyd 2ys)*ls d som 2od%)%os
os%oph%l%*
T5) *d pho)om%2o*phs/ N%2/m* 4*)holoy %%)*l Im* *lly
LOT@ OM ONO!"T@;
)ypho%d (+
.*d *lom*)os po.lms
TB
.2llos%s!oh's d%s*slposydp (%s*2o%dos%so)hs
? 2ho%2 *)o%mm d%s*s
hm*)o%d *)h%)%s %s $o)h mm.%
? %2))s%*l d%s*s o()F d (l*
? d%ssm%*)d 2*2 o22*s%o*lly
LOT@ OM L"4O!"T@;
0%(2)%os moo2los%s0 s .lo$
$hoop% 2oh 0p)ss%s0F l%))l 2l*+d lympho2y)sF )h )o5% ps
)h T-2lls (om hom% )o lympho%d )%ssF Am/ / !l%/ 4*)h/ 11D; 3E,>
-
7/24/2019 White Cell Disorders i
17/105
0)*s%) s)ss lympho2y)os%s0 *.sol) 2o)s D
-
7/24/2019 White Cell Disorders i
18/105
%mmo.l*s)s -- .% 2lls, .%) 2lol%, pl)y o( .l-s)*%%2y)opl*sm
4o.*.ly mo %mpo)*) % spo))% %(2)%os moo *d )ll% %)(om lm%* $h yo' * .% %s )h*) $h )h *.2h o( 0*)yp%2*l lympho2y)s0, o )$o loo )h s*m/
I(2)%os moo2los%sBlood p%2)
6.4*)h 4ho)o
I(2)%os oo2los%sT5) *d pho)om%2o*phs/ N%2/
m* 4*)holoy %%)*l Im* *lly
LOT@ OM BA@O4IL@;
2ho%2 myloos lm%*
o)h 02ho%2 mylopol%(*)%+ d%sods0
poly2y)hm%* +*
? p%m*y hmoh*%2 0ss)%*l0 )hom.o2y)hm%*
? spposdly % lo)s o( o)h )h%sF )h%s $%ll o) . %mpo)*)2l%%2*lly/
NOT; No o( )hs 02l*ss%2 (%d%s0 %s %)h p*)%2l*ly ss%)%+, op*)%2l*ly sp2%(%2, (o *y p*)%2l* d%s*s/ Us )h%s %(om*)%o %)h s))% o( )h 0$hol pso0/
O NUTRO4IL@;
http://library.med.utah.edu/WebPath/HEMEHTML/HEME013.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME013.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME013.htmlhttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME013.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME013.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME013.htmlhttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.microscopyu.com/galleries/pathology/index.html -
7/24/2019 White Cell Disorders i
19/105
6 h*+ *l*dy m)%od !RONI! RANULOATOU@ I@A@,* pooly-*md op o( d(2)s % )h *.%l%)y o( )oph%ls )o %ll
2ommo .*2)%*, $%)h )h m*2oph*s d% )o .2om %+ol+d*s $ll/
Th mos) (*m%l%* %s 0-l%d 2ho%2 *lom*)os d%s*s0,$h%2h h*s o$ . 2d .y )h*py N*)/ d/ 1>; D
-
7/24/2019 White Cell Disorders i
20/105
most o# the rest! Don5t miss it!
6 A similar, than"#ully-rare periodi #e$er
syndrome is aused 1y a mutation in the
TNF-reeptor 3TNFR+4) 7lood +(0) +/(,((8! 9et another is aused 1y mutated
ryopyrin 3inludes serious neurologi
pro1lems anti-interleu"in-+ treatment1rings a1out #ull resolution) Neurology *:)
+8*, (+(4!
"o 2*ll !IAK-IA@I @"NRO, % $h%2h )h * s+*lpo.lms $%)h o*ll mm.* sy)hs%s/ sy)hs%s/
N)oph%l lysosoms * l* *d pom%) )hy (s $%)h*2h o)h *d do o) (s $%)h ph*osoms, so )h's poo.*2)%*l %ll% *d * lo) o( %(2)%os/
l*osoms do') (om poply, so )h %s p*)%*l *l.%%sm/
Th l*2 o( pl*)l) ds *ls sl)s % * .ld% )d2y/
? Th h*s . 2lod L"@T, lysosom*l )*((%2 l*)o/os) o( )hs p*)%)s o o )o d+lop * l)h*l o-opl*s)%2
hyppl*s%* o( )h lympho2y)s/ *o$ C s)m 2ll )*spl*) %so$ o)% *d p+)s )h%s/ R+%$ Blood 9E; 979, >
-
7/24/2019 White Cell Disorders i
21/105
-
7/24/2019 White Cell Disorders i
22/105
!! pho)o
NORAL L"4 NO ANATO"
L"4 NO@ * so() %//, )%2l%-(*m$o o+o%ds, p )o *.o) >2m % h*l)h/ A(() lymph*)%2s p)*) *d )*+l $%)h% )h%2*psls m)*s)*)%2 2*2 (%s) s)s p h/ A()$*ds, lymphp2ol*)s )hoh )h 2o)5, *d )h )h mdll*, l*+% .y )hh%lm/
6%)h% )h 2o)5, )h * *lly som m%*l 2)s0lympho%d (oll%2ls0, s%)s o( *2)%+ly-pol%(*)% B-2lls/ *2hm%*l 2) %s sodd .y * m*)l o( s)% B-2lls,$h%2h * % ) sodd .y 0p**(oll%2l*0 T-2lls/ I( )h %s
o *)%%2 s)%mls, yo'll s oly 0p%m*y (oll%2ls0 o( slpyB-2lls % )h 2o)5/
Th 5) )%m yo ) )o loo *) * m%*l 2) d )hm%2os2op, 2h2 o) )hos pol%(*)% B-2lls/ ThsJ2 (om sm*ll B-2ll )o pl*sm* 2ll %s %)s)% *ds % mos) h%s)oloy 2oss/ "o'll d )o o$ )h%s)o ds)*d 2l*ss%2*l *22o)s o( lymphom*s;
Rs)% sm*ll B-lympho2y)
@m*ll 2l*+d 02l()d0, %//, (oldd-2ls B-lympho2y)
L* 2l*+d B-lympho2y)
@m*ll o-2l*+d B-lympho2y)XNOT; Th%s 2ll %s *s l* *s * l* 2l*+d B-lympho2y)Y
L* o-2l*+d B-lympho2y)
B-%mmo.l*s)
moy B-2lls / / *d / / 4l*sm* 2lls
http://www.pathguy.com/lectures/ehrlichiosis.jpghttp://www.pathguy.com/lectures/ehrlichiosis.jpghttp://www.pathguy.com/lectures/ehrlichiosis.jpg -
7/24/2019 White Cell Disorders i
23/105
6%)h% )h mdll*y 2ods, 5p2) )o s * m%5 o( B- *d T-2lls *dpl*sm* 2lls/ Th s%so%ds * l%d .y (%5d ph*o2y)s/
sp%) )h l*) p%2)s % h%s)oloy .oos, lymph ods *sldom 0om*l0, sp2%*lly % *dl)s/
L"4ANITI@; I(l*mm*)%o o( )h lymph ods
A!UT L"4ANITI@ ds2%.d % 0B% Ro..%s0 %s o) m2h mo)h* )h hyppl*s%* % * *2)%+ od/
Lo2*l%:d lymph*d%)%s %s mos) o() d )o * .*2)%*l %(2)%o% )h ** d*%d .y )h lymph od/
R*lly .*d 2*ss h*+ polys *d + *.s2ss (om*)%o
$%)h% )h ods/ Th d sl) $%ll . * s2*d-p lymphod/ "o h*+ o o mo/
*l%:d lymph*d%)%s ss)s * sys)m%2 +%*l %(2)%o/
0s)%2 *d%)%s0, o() %d%s)%%sh*.l (om *2)*ppd%2%)%s, %s 2*sd .y "s%%* )o2ol%)%2*/
A2) lymph*d%)%s, s%2 %) 2oms p sddly *d s))2hs)h 2*psl, %s l%ly )o m* )h od )d/
!RONI! NON-@4!IMI! L"4ANITI@ (*lls % o o( )hd%s)%2)%+ p*))s/
MOLLI!ULAR "4R4LA@IA %//, lo)s *d lo)s o( .% (oll%2lssl)s (om los)*d% 2o)*2) $%)h o*%sms o 0o)h )h%s0)h*) s)%ml*) )h B-2lls/ I( ppl5d, )h% o(;
)o5opl*smos%s ? loo (o m%%-*lom*s )o2h% )hm%*l 2)s *) )h% ds, )h%s %s spposdly
p*)hoomo%2F som o( )hs * ops o( m*2oph*sFsom * .% 0moo2y)o%d B-2lls0 sp2%*lly % )hmdll*
hm*)o%d *)h%)%s o() lo)s o( pl*sm* 2lls
-
7/24/2019 White Cell Disorders i
24/105
syph%l%s pl*sm* 2lls % )h mdll*, m%%-*lom*s,sp%o2h)s
AI@-l*)d 2ompl5 C ps%s)) *l%:dlymph*dop*)hy o( I %(2)%o/
2ommo +*%*.l %mmod(%2%2y %((2)%+ B-2ll*2)%+*)%o
{36371})o5opl*smos%sF m*y .s % * 2ll{40654})o5opl*smos%sF )%ss *2)%o l*m-loo% *lom*s
@yph%l%s % * lymph od
")** Ts)sm%
To5opl*sm* lymph*d%)%s
")** Ts)sm%
Moll%2l* hyppl*s%*
6.4*)h 4ho)o
Moll%2l* hyppl*s%*
6.4*)h 4ho)o
Moll%2l* hyppl*s%*
6.4*)h 4ho)o
I lymph*dop*)hy
")** Ts)sm%
4ARA!ORTI!AL L"4OI "4R4LA@IA %//, lo)s *d lo)s o(lympho2y)s, %2ld% )d-o os, % )h T-2ll %os o( )h2o)5 -- o() *s%s) )o 2o%: )h )h ps2 o( pom%).lood +ssls sl)s (om los)*d% 2o)*2) $%)h o*%smso 0o)h )h%s0 )h*) s)%ml*) )h T-2lls/ I( ppl5d, )h% o(
%(2)%os moo2los%s, !
phy)o% 0%l*)%0 5pos
$%d *2)%os )o * +*22%
%(2)%os moo2los%s (*m%ly )hos *y T-%lls, )2/F? 5p2) )o s lo)s o( .% lympho%d 2lls $%)h p*l
http://www.pathguy.com/sol/36371.jpghttp://www.pathguy.com/sol/40654.jpghttp://info.fujita-hu.ac.jp/~tsutsumi/case/case216.htmhttp://info.fujita-hu.ac.jp/~tsutsumi/case/case216.htmhttp://info.fujita-hu.ac.jp/~tsutsumi/case/case215.htmhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME032.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME032.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME033.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME033.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME120.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME120.htmlhttp://info.fujita-hu.ac.jp/~tsutsumi/case/case218.htmhttp://info.fujita-hu.ac.jp/~tsutsumi/case/case218.htmhttp://www.pathguy.com/sol/36371.jpghttp://www.pathguy.com/sol/40654.jpghttp://info.fujita-hu.ac.jp/~tsutsumi/case/case216.htmhttp://info.fujita-hu.ac.jp/~tsutsumi/case/case216.htmhttp://info.fujita-hu.ac.jp/~tsutsumi/case/case216.htmhttp://info.fujita-hu.ac.jp/~tsutsumi/case/case215.htmhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME032.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME032.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME032.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME033.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME033.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME033.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME120.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME120.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME120.htmlhttp://info.fujita-hu.ac.jp/~tsutsumi/case/case218.htmhttp://info.fujita-hu.ac.jp/~tsutsumi/case/case218.htmhttp://info.fujita-hu.ac.jp/~tsutsumi/case/case218.htm -
7/24/2019 White Cell Disorders i
25/105
2y)opl*sm, pl)y o( 2os%s *d m%)o)%2 (%sF s *y! 2llsF )h%s 2* . * *l (ool (o lymphom*, s
A2h/ 4*)h/ L*./ d/ 117; >9, 1993
lps loo (o (* +*s2l%)%s *d + %os o(
%(*2)%o
@INU@ "4R4LA@IA (omly 0s%s h%s)%o2y)os%s0F %//,s%so%ds $%)h s$oll do)hl%*l 2lls *d lo)s o( h%s)%o2y)s/ I(ppl5d, )h% o(;
ods d*%% * 2*2 .y o m*s sp2%(%2
? ods %V2)d $%)h pm*) *d%oloy 2o)*s) md%m0lymph*%o*m dy0 o (o som *so 2o)*%%m%*l o%l 0olo*lom*s0
6h%ppl's d%s*s 6h%ppl 2lls
? !*s)lm*'s %*) *%o(oll%2l* lympho%d hyppl*s%* (*.yod yo l*% o.V2)%+sF N 33, 199DFo 2*s sp2%*lly $h ml)%(o2*l *d %2h % pl*sm*2lls sms )o . hps 8 C K@ Am/ / 4*)h/ 1E1;1E17, 1997F 6s)/ / d/ 17; 38, 1997F Blood 93; 3D3,1999/ I) %s * (*mos 2*s o( p**opl*s)%2 pmph%sL*2) 33; E>E, >
-
7/24/2019 White Cell Disorders i
26/105
6 ?sinus histioytosis with massi$elymphadenopathy and lymphoyte
emperipolesis? 3Rosai-Dor#man disease4) a
presuma1ly $iral, generally sel#-limited semi-disease o# young people! 7- and T-ells li$einside marophages 3?emperipolesis?4, whih
in turn light up with +(( and #or lipid!
There is a more ominous eBtranodal #orm aswell! No one understands it!
Ros*%-o(m*@1
-
7/24/2019 White Cell Disorders i
27/105
6ll-m*d *lom*s $%)h NOTIN ls * po.*.lys*2o%dos%s/ Also mm. !oh's, .yll%os%s, *d odsd*%% od%'s d%s*s/
*lom*s $%)h 4U@ % )h% 2)s * po.*.ly 2*sd .y o
o( )h (ollo$%; 1 lympho*lom* +m , > 2*) s2*)2h(+, 3 .2llos%s, D pl* , E )l*m%* , l*ds-ml%o%dos%s, *d 7 o)h ys%%* %(2)%os/ I( yo 2* (%d oo( )hs, 2os%d 8 -l%d 2ho%2 *lom*)os d%s*s)h )oph%l dys(2)%o po.lm/
? *lom*s $%)h 2)*l 2os%s $%)h m2h *yoh5%s .) ops; K%2h%-MV%mo)o/ @ .lo$/
T.2los lymph*d%)%s*) l*.ls
Rom*%* 4*)holoy A)l*s
B*)ollos%s!*) s2*)2h (+
")** Ts)sm%
"o h*+ po.*.ly *l*dy s )h 6*)h%-M%ldy %*) 2lls o(
m*sls $%)h% m%*l 2)s/ Thy sho$ +*%*.l %mmolo%2m*s -- B-2ll, T-2ll, *dCo dd%)%2 m*2oph*s/ @om h*+%)*2l* m*sls +%s %2ls%osF som do o)/
? KIKU!I-MUIOTO N!ROTIZIN I@TIO!"TI!L"4ANITI@ / Am/ A2*d/ m/ E9; 13
-
7/24/2019 White Cell Disorders i
28/105
L"4ANO4AT" %s * 2l%%2%*'s $od (o * .% lymph od/
NON-OKIN'@ L"4OA@; By d(%%)%o, moo2lo*l, m*l%*) )moso( )h B- o T-2lls, *d o) o( pl*sm* 2lls, *d o) od%'s d%s*s/ By2s)om, so() )mos o( moo2y)s * %2ldd h .2*s )hy loos%m%l*/
Ths * )h 2ommo p%m*y )mos *%s% % )h lympho%d )%sslymph ods, )os%ls, *do%ds, spl, 4y's p*)2hs, o-p%)hl%*l)hyms *d )h * som sp2%*l 2*ss/ 6 2o+ !N@ lymphom*s% )h 0o0 s2)%oF )h o)loo (o p%m*y !N@ lymphom* %s s)%ll0d%sm*l0; !*2 11
-
7/24/2019 White Cell Disorders i
29/105
/ 6*o2's !oll2)%o
M!! lymphom*4%))s.h 4*)holoy !*ss B-2ll lymphom*4%))s.h 4*)holoy !*ss
%((s l* 2ll lymphom**)
4%))s.h 4*)holoy !*ss
B-2ll lymphom*L* 2ll
4%))s.h 4*)holoy !*ss
Moll%2l* lymphom*, spl
AMI46%%md%* !ommos
Th o-od%'s lymphom*s * * s.V2) o( p%*l(*s2%*)%o (o p*)holo%s)s/ *% )h d%*os%s 0.% om*l%*)0 %s o() )oh, *d 2l*ss%(y% )h o-od%'slymphom*s h%*() 0lymphom*s0 $*s * m*Vo %)*)%o*l2omp)%)%+ spo) )hoh )h 198
-
7/24/2019 White Cell Disorders i
30/105
RUL; os) o-od% lymphom*s * som$h*) mo 2ommo %m, $%)h )h mos) poo2d d%((2 po.*.ly .% T-lympho.l*s)%2 lymphom* G >;1/
RUL; Bl*2s *d 2h%ld *lmos) + ) odl* lymphom*s/
RUL; A ($ sp2%(%2 lymphom*s h*+ o o mo sp2%*l %s (*2)os%//, hl%2o.*2) 2*ss )h ALT lymphom* o( )h s)om*2hF l))op*)hy 0sp0 2*ss * 2%os p*% o( T-2ll lymphom*s;*s)o)/ 13>; 19, >
-
7/24/2019 White Cell Disorders i
31/105
891, 1998, O22p/ +%o/ d/
-
7/24/2019 White Cell Disorders i
32/105
RUL; Th lo$ )h *d o( )h lymphom*, )h OR l%ly )h .om*o$ %s )o . %+ol+d *) )h )%m o( d%*os%s/ 4**do5%2*l, o
RUL; Lymphom*s )d )o sp*d )o s%)s *22od% )o )h% B-2ll o T-2ll o%%/ B-2ll )mos o )o )h m%*l 2)s, )h% m*)ls, *d
)h o)s%ds o( )h spl%2 $h%) plp/ T-2ll )mos )o )h *)%omd%*s)%m, p**2o)%2*l %os o( ods, %s%ds o( spl%2 $h%)plp, )2/ @% lymphom*s * s*lly o( T-2ll o%%/
RUL; Th m*l%*) 2lls o( lymphom*s * OR %(om )h* )hm%5 o( 2lls om*lly s % lympho%d )%ss, *d )hy 2*p%)l*)som ph*s % )h l%( h%s)oy o( %)h om*l B-2lls o T-2lls/ o')5p2) )o s m2h 02y)olo%2 *)yp%*0 % * lymphom*/ Rmm. )h*))h om %s s*lly o) ds)*.%l%:d % lymphom*s/ sp2%*lly,%mmo.l*s)%2 lymphom*s 2* loo p))y $%ld/
RUL; Lymphom*s )h*) o$ *s odls $%)h% * lymph od 0)y% )o. m%*l 2)s0 * 2*lld NOULAR o MOLLI!ULARsyoyms/ Thy * *l$*ys o( B-2ll o%%, *d )h lymphom* 2lls$%ll 2losly sm.l o o( )h (oms % )h sJ2 (om s)% B-lympho2y) )o pl*sm* 2ll/
{23581}odl* lymphom*
Nodl* lymphom*
6.4*)h 4ho)o
Nodl* lymphom*
KU !oll2)%o
RUL; Nodl* lymphom*s )d )o . %dol) ls%os $%)h *)*lh%s)o%s )h*) * l*)%+ly *((2)d .y 2l*ss%2*l 2hmo)h*py/%s)o%2*lly, )hy h*+ . %2*.l, )hoh )h%s sms )o .2h*%/ *2h odl* lymphom* h*s * .)) poos%s )h* %)sd%((s 2o)p*), *d %s l%ly )o )*s(om %)o %) soo o l*)/ Th%s
m*s ss, s%2 (oll%2l (om*)%o %s * s% o( ood d%(()%*)%o/Lss o(), * odl* lymphom* )*s(oms %)o * d%((s l*-2ll o%mmo.l*s)%2 lymphom*/
? A lymphom* $%)h )$o d%(() mopholo%2 *pp**2s *d)%2 2los %s * 02ompos%) lymphom*0/ Th%s %s (*%ly 2ommo,*d m*y ps) )*s(om*)%o o( o lymphom* %)o *o)h
http://www.pathguy.com/sol/23581.jpghttp://library.med.utah.edu/WebPath/HEMEHTML/HEME034.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME034.htmlhttp://www.pathguy.com/lectures/nodular_lymphoma.jpghttp://www.pathguy.com/lectures/nodular_lymphoma.jpghttp://www.pathguy.com/sol/23581.jpghttp://library.med.utah.edu/WebPath/HEMEHTML/HEME034.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME034.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME034.htmlhttp://www.pathguy.com/lectures/nodular_lymphoma.jpghttp://www.pathguy.com/lectures/nodular_lymphoma.jpghttp://www.pathguy.com/lectures/nodular_lymphoma.jpg -
7/24/2019 White Cell Disorders i
33/105
.y *dd%)%o*l m)*)%os, o )$o sp**) m*l%*) )mos/))% %) $od o); Am/ / !l%/ 4*)h/ 99; DDE, 1993F Am/ /4*)h/ 1ED; 18E7, 1999F N3D1; 7D, 1999/ Th mos) (*m%l%*!LLC6LL m%5d % $%)h (oll%2l* lymphom* %s )$o d%(()2lo*l )mos Am/ / !l%/ 4*)h/ 137; D7, >/
RUL; os) odl* lymphom*s o( *ll %ds (*) o o( )$o2h**2)%s)%2 )*slo2*)%os, %)h )11F1D o )1DF18/ *2h %+ol+s)h %mmolo.l% h*+y-2h*% %o o 2homosom 1D/ Th%s %s.oh) %)o 2o)%%)y %)h $%)h )h .2l1 C 4RA C 2y2l% 1 o2oo 2homosom 11 o )h .2l-> o2o o 2homosom 18/
? A m*Vo%)y o( *dl)s h*+ som )1DF18 lympho2y)s o .o*d %(yo loo h*d; N 3E; 7D1, >
-
7/24/2019 White Cell Disorders i
34/105
*m 4@UOL"4OA/ %s)%%sh% )hs (om *l lymphom*s%s * 2h*ll/
Also mm. )h*) 2)*% *)o%mm d%s*ss (*) h*+ypoly2lo*l lympho%d %(%l)*)%o o( s*l%+*y l*ds @Vo's,
)hyo%d *sh%mo)o's, %sl)s )yp I d%*.)s, o %dys*)o%mm %)s)%)%*l ph%)%s/
? Mo som *so, Lym d%s*s pod2s psdolymphom*s% )h * lo.s/ No o h*s * 2l $hy/
RUL; 4*)holo%s)s )y% )o d%s)%%sh m*l%*) lymphom*s (om.% lymph od hyppl*s%*s *d psdolymphom*s p*y sp2%*l*)))%o )o;
1 MMA!NT OM T NORAL L"4 NOAR!IT!TURF
> !LL UNIMORIT" 0moo)oy0, ss)s lymphom*, .)+ (oll%2l* lymphom*s * %(%l)*)d .y )h s*m .% 2lls*s o$ % * m%*l 2)F
? 3 4s2 o( m*2oph*s l*d $%)h 2l* d.%sTINIBL BO" A!RO4A@, * s% )h*) )h po2ss %sITR .% OR * h%h-*d lymphom*, .2*s % lo$-
*d lymphom*s yo $o') s m2h *pop)os%sF
D 6%dsp*d .2l-> po)% s)*%% %s * p))y ood s% )h*))h%s %s lymphom*/
T%%.l .ody m*2oph*s
6.4*)h 4ho)o
E A@!ULAR 4ROLIMRATION $ +ssls ss) )h
po2ss %s .%, *dF
INA@ION o( sod% )%ss 02*psl* )*sss%o0,ss)s lymphom*/
http://library.med.utah.edu/WebPath/HEMEHTML/HEME121.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME121.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME121.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME121.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME121.html -
7/24/2019 White Cell Disorders i
35/105
7 N!RO@I@ *p*) (om *pop)os%s %s 2ommo % somlymphom*s, *d o( 2os % 2o)%:% %(2)%os, .)2ommo % d%((%2l) .% ls%os/
8 I( 0(oll%2ls0C0odls0 * ps), )h AB@N! OM A
ANTL o( sm*ll lympho2y)s *od )h l%h) s%d o( )h (oll%2lss)s m*l%*2y/
? I AI@, m*)ls * l%ly )o *.s)/ 6hy
9 Tod*y's p*)holo%s), *s% 0Is )h%s lymphom*0, .%s *s(ollo$s;
I( %) %s *pp*)ly m*d o( sm*ll lympho%d 2lls, )hp*)holo%s) s)*%s (o *pp* *d l*m.d* moo2lo*l%)y %s
lymphom*, poly2lo*l%)y %s o-m*l%*), *d * .2l> s)*%%( )h * odls pos%)%+ s)*%% %d%2*)s lymphom*/
I( %) %s *pp*)ly m*d o( l* lympho%d 2lls, )hp*)holo%s) $%ll od * !DE lo2y) 2ommo *)%,pos%)%+ % lymphom*s, * ($ o)h lympho2y) m*s,2y)o*)%s *)%+ % lymphom*s, *d * ($ ml*om*m*s *)%+ % lymphom*s/
Lymphom* % lymph od
I+*s%o o( sod% (*)Tom m*'s @%)
1
-
7/24/2019 White Cell Disorders i
36/105
RUL; os) lymphom*s od%'s *d o-od%'s m*y 2*s*l%:d dys(2)%o o( .% B-2lls hypo*mm*lo.l%m%*,$%)h sl)% )d2y )o %(2)%o/
!LA@@IMI!ATION @!@;
Ayo s% )h )ms 0lymphos*2om*0, 0%*) (oll%2l*lymphom*0, o 0)%2lm 2ll s*2om*0 % )od*y's md%2% %s)%.ly o) o( d*)/
? T 19 RA44A4ORT !LA@@IMI!ATION %s *2h*%2 .) s)%llpopl*/ I) $*s .*sd o 2)*% %2o2) .) o2-s(l*ssmp)%os *.o) )h *) o( )h 2lls s % )hs ls%os;
06ll-d%(()%*)d lympho2y)0/// loos l% * om*l
s)% lympho2y)
04ooly-d%(()%*)d lympho2y)0/// dos') loo l% *om*l s)% lympho2y), .) %s sm*ll )h* *do)hl%*l 2ll
0%s)%o2y)0/// .% )h* * do)hl%*l 2ll, *d h*s lo)s o(2y)opl*sm
0Ud%(()%*)d 2ll0/// .% )h* * do)hl%*l 2ll, *d
h*s oly * l%))l 2y)opl*sm
Lymphom*s $ ()h s.-d%+%dd %)o 0odl*0 *d0d%((s0, dpd% o )h% o$)h p*))/ sp%) %)sl%m%)*)%os, )h R*pp*po) sys)m $*s s(l *s lymphom*s$ .% so)d o)/
? T 197D LUK@-!OLLIN@ !LA@@IMI!ATION $*s .*sd op%m%)%+ %mmo)yp% *d 2los 5*m%*)%o o( )h mopholoyo( )h 2lls, $h%2h $ 2omp*d )o )hos % )h 2)s o(
om*l m%*l (oll%2ls/ A2)%+*)d-)yp B-2lls (om sm*ll-2l*+d )hoh l*-o2l*+d 2lls $ *ppop%*)ly 2*lldMOLLI!ULAR !NTR !LL@/ + mo 52%)% $ )hIUNOBLA@T@, +y .% od 2lls $%)h +y .% od 2l%.*% % )h% 2)s * s%l +y .% 2lols I 2*ll )hm0y.*ll 2lls0/
-
7/24/2019 White Cell Disorders i
37/105
? T 198> 6ORKIN MORULATION $*s * 2osss o(5p)s .*sd oly o mopholoy/ I) $od %2ly )%l %) $*sspsdd .y )h R+%sd op*-Am%2* sys)m/ "o'll s)%ll(%d popl s% )hs )ms/
LO6 RA L"4OA@ )*)d s+%+*l h*sh%s)o%2*lly . %s *od 1< y*s
@m*ll lympho2y)%2
@m*ll lympho2y)%2, pl*sm*2y)o%d
Moll%2l*, sm*ll 2l*+d 2ll
Moll%2l*, m%5d sm*ll-2l*+d *d l* 2ll
INTRIAT RA L"4OA@ )*)d s+%+*lh*s h%s)o%2*lly . *od E y*s
Moll%2l*, l* 2ll
%((s, sm*ll 2l*+d 2ll
%((s, m%5d sm*ll-2l*+d *d l* 2ll
%((s, l* 2llI RA J%2 d*)h )*)d, .) $ h*+ .2% )hs $%)h 2l*ss%2*l 2hmo)h*py s%2 )h 197
-
7/24/2019 White Cell Disorders i
38/105
T RI@ URO4AN-ARIAN !LA@@IMI!ATION OML"4OI NO4LA@@ 0RAL0, l*sd % 1993, $s .*sd o$ $o $%)h d%(()%*)%o m*s/ I)s ps) (oml*)%o %2ldssl%h) *l)*)%os mos) 2)ly % >
-
7/24/2019 White Cell Disorders i
39/105
T-2ll polympho2y)%2 lm%*T-2ll l* *l* lympho2y)%2 lm%* )h%s 0!LL0+*%*) 2*ss *ly *m%* C m*o$ .o)F pd*) Am// !l%/ 4*)h/ 13; >89, >
-
7/24/2019 White Cell Disorders i
40/105
% lymphopol%(*)%+ d%s*s dsp%) )h 6OF ho$+, poplo )hs md%2%s * po )o d+lop lympho%d hyppl*s%*sod/ 4*)h/ >>; 1E3>, >
-
7/24/2019 White Cell Disorders i
41/105
Aod 3
-
7/24/2019 White Cell Disorders i
42/105
? 6h%l 6*lds)om's %s )h mos) 2ommo 2*s o( )hhyp+%s2os%)y sydom, yo m*y *lso s %) % som pl*sm* 2llmylom* p*)%)s, o $h )h * )oo m*y d 2lls s*lly% poly2y)hm%* +*, o )oo m*y $h%) 2lls s*lly % 2ho%2myloos lm%*, o o o( )h d%s*ss $%)h $*y )oom*y 2hylom%2os, o $%)h * 2yolo.yl% o +y .*d poly2lo*l*mmop*)hy, o $%)h $*y o )oo m*y pl*)l)s )h *sos *2ompl%2*)d, %+ol+% pl*)l)-do)hl%m %)*2)%os, *dl% )h o)hs, )h .lood po.*.ly $o') . hyp+%s2os % )hl*./
6*lds)om's4%))s.h 4*)holoy !*ss
AL4A A"-!AIN I@A@ o$ mo+d *lo $%)h )ho)h h*+y-2h*% d%s*ss %)o )h pl*ms*-2ll opl*smss2)%o o( )h 6//O/ 2l*ss%(%2*)%o )yp%2*lly *((2)s )h sm*ll.o$l *d %s (*%ly 2ommo % )h N*-*s)/ os) +%2)%ms *yo *dl)s, $ho ps) $%)h m*l*.sop)%o/
{13673}h*+y 2h*% d%s*sF pl*sm*2y)o%d 2lls % %)s)%*l m2os*
? Th%s )*s(oms %)o )h *ss%+ 0d%)***.dom%*l lymphom*0, * B-2ll %mmo.l*s)%2 lymphom*/
{19504}d%)** lymphom*, sm*ll .o$l
Alph* h*+y 2h*%s * *lso pod2d .y ALT lymphom*s/
AA A"-!AIN I@A@ %s * m* (o * mo*ss%+ lymphom* )h*) *lly *((2)s )h ldly/ Loo (o.% )os%ls/
U A" !AIN I@A@ *lly )s lm%2 *ly/
IMMU@ LAR B-!LL L"4OA
Th mos) 2ommo o( )h o-od%'s lymphom*s/
http://path.upmc.edu/cases/case69.htmlhttp://path.upmc.edu/cases/case69.htmlhttp://www.pathguy.com/sol/13673.jpghttp://www.pathguy.com/sol/19504.jpghttp://path.upmc.edu/cases/case69.htmlhttp://path.upmc.edu/cases/case69.htmlhttp://path.upmc.edu/cases/case69.htmlhttp://www.pathguy.com/sol/13673.jpghttp://www.pathguy.com/sol/19504.jpg -
7/24/2019 White Cell Disorders i
43/105
B(o )%2 po(%l%, $ $ )h*) !O4 2hmo)h*py h*s2d *od D
-
7/24/2019 White Cell Disorders i
44/105
? o') $oy *.o) )h d)*%ls (o p*)holo%s)s/ Th * 5)*-*ss%+ 0.l*s)o%d0 *d 0plomoph%20 s.)yps, )2/, )2/,
ALT L"4OA 0m*l)om*0, *md (o %)s o222 o o m2os*ls(*2s, o( 2os %s o$ d(%d .y %)s * )*dm* )*slo2*)%o
)11F18 *d (s%o po)% A4I>CALT1F A/ / 4*)h/ 1>; 1113, >
-
7/24/2019 White Cell Disorders i
45/105
MOLLI!ULAR L"4OA@ !BC!! lymphom*
Momly d%+%dd %)o 0sm*ll-2l*+d0, 0m%5d sm*ll-2l*+d *dl* 2ll0 *d 0l*-2ll0 s.2*)o%s, %)'s o$ p))y 2l* )h*)mos) o( )hs lymphom*s * m%5)s o( 2)o.l*s)s l* B-
2lls $%)h o-2l*+d 2l% *d 2)o2y)s 2l*+d B-2lls --.o)h sm.l 2lls % )h m%*l 2)s/ Thy o$ *s odlssodd .y .% lympho2y)s mos)ly T-2lls/
Th 0sm*ll 2lls0 C 2)o2y)s loo l% om*l lympho2y)s52p) (o o o mo 2l()s p )h 2ls 0.))o2 2ll0, )2/,*d )hy l*2 )h m*.ly h)o2hom*)%/
Th 6old *l)h O*%:*)%o h*s * *d% sys)m;
*d 1 ($ )h* E 2)o.l*s)s p h%h po$ (%ld --%dol) d%s*s
*d > -1E 2)o.l*s)s ph h%h po$ (%ld -- %dol)d%s*s
*d 3* mos)ly 2)o.l*s)s $%)h som 2)o2y)s --%dol) d%s*s
*d 3. *lmos) *ll 2)o.l*s)s -- 2ommo, *ss%+d%s*s
4*)%)s * s*lly % m%ddl-*d o old/ Th .o m*o$ %ss*lly %+ol+d *) )h )%m o( d%*os%s/ Th )*slo2*)%o)1DF18, $%)h .2l>, %s s*l/
I( oly * m*ss %s d%s2o+d *d )h * o symp)oms, mos)phys%2%*s )od*y 2ommd do% o)h%F %) )*s * *+*o( 3 y*s (o symp)oms )o *pp*/ Tod*y )hy * *sy )o )*)
-
7/24/2019 White Cell Disorders i
46/105
%%)%*lly, .) )d 2 p*)dly *() )*)m) .%s, *2h)%m soo )h* l*s)/
A.o) h*l( o( )hs )*s(om %)o * d%((s B-2ll lymphom*F )h)*s(om*)%o %s o() *22omp*%d .y *l%:d symp)oms
ph*ps (o )h (%s) )%m *d )h d%s*s .2oms h*d )om**/
{23599}m%5d lymphom*F s )h do)hl%*l 2ll *) >;3< *s * s%: m*{23683}m%5d lymphom*
{23596}odl* l*-2llF *) )h%s po$, Vs) *pp2%*) )h odl*%)y{23581}odl* lymphom*
L* 2ll lymphom*
6.4*)h 4ho)o
L* 2ll lymphom*
6.4*)h 4ho)o
Tll% odl* lymphom*s (om hyppl*s)%2 m%*l 2)s;
Lymphom* odls * s*lly .2l->F m%*l 2)s *s*lly .2l-> *)%+
Lymphom* odls l*2 )h l%h)-s%d C d*-s%d $ s*llys % m%*l 2)s
Lymphom* odl* $%ll *lly sho$ 2lo*l%)y %//, *ll-*pp* o *ll-l*m.d*F m%*l 2)s *l$*ys h*+ * m%5
Lymphom* odls ((*2 )h om*l dly%*2h%)2) o( )h lymph od
Lymphom* odls o() o$ .*2-)o-.*2 *d 2o$d o
*o)h, $h%l m%*l 2)s s)*y 2l* o( o *o)h
Lymphom* odls m*y sho$ m*)ls l% om*l m%*l2)s, .) )hy )d )o . )h%
OR L"4OA@
http://www.pathguy.com/sol/23599.jpghttp://www.pathguy.com/sol/23683.jpghttp://www.pathguy.com/sol/23596.jpghttp://www.pathguy.com/sol/23581.jpghttp://library.med.utah.edu/WebPath/HEMEHTML/HEME036.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME036.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME037.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME037.htmlhttp://www.pathguy.com/sol/23599.jpghttp://www.pathguy.com/sol/23683.jpghttp://www.pathguy.com/sol/23596.jpghttp://www.pathguy.com/sol/23581.jpghttp://library.med.utah.edu/WebPath/HEMEHTML/HEME036.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME036.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME036.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME037.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME037.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME037.html -
7/24/2019 White Cell Disorders i
47/105
{23590}d%((s sm*ll 2l*+d lymphom* *ll yo 2* )ll %s )h*) %) %s sm*ll2l*+d{23593}d%((s sm*ll 2l*+d lymphom* *ll yo 2* )ll %s )h*) %) %s d%((s{46344}d%((s sm*ll 2l*+d lymphom*, m*o$
{23581}odl* lymphom*
@m*ll 2l*+d lympho2y) % .loodd Llo's 4*)holoy *lly
ANA4LA@TI! LAR !LL L"4OA A2h/ 4*)h/ L*./d/ 13E; 19, >FE $%)h pod2)%o o( * (s%o pod2) o2oN4CALK, Blood 93; 3
-
7/24/2019 White Cell Disorders i
48/105
o5ymooF h%s)%o2y)s * o) lympho2y)s/ Th %mmos)*%%*d 2homosom*l s)d%s $%ll 2l*%(y +y)h%/
{23674}) h%s)%o2y)%2 lymphom*, )s) m
Th old 0%mmo.l*s)%2 lymphom*0 o( )h 6o% !l*ss%(%2*)%o$*s * m%5 o( s+*l d%(() B- *d T-2ll lymphom*s/
MMU@ION L"4OA@, % )h .ody 2*+%)%s $%)ho) * sol%dph*s, * s*lly s % %mmosppssd popl *d *l$*ys* 2*sd .y K@ hps 8 L*2) 3D; 883, 199EFL*2) 3D7; 98< & 1, 199/ K@ %s o$ J%d (o 2*sd(%%)%o !*2 111; >>D, >
-
7/24/2019 White Cell Disorders i
49/105
{15446}lymphom*, p%m*y % )h s)om*2h{15542}lymphom*, p%m*y % )h s)om*2h
T-L"4OBLA@TI! L"4OA
Th%s %s )h mos) %mpo)*) pd%*)%2 lymphom* )yp%2*lly *)*d's y's d%s*sF %) %s )h sol%d 2o)p*) )o T-2ll*2) lympho.l*s)%2 lm%*/
? Ths sm*ll%sh T-2lls h*+ 2o+ol)d %//, mo )h* o2l() 2l%, )hoh )hy * o) *s 2ompl5 *s % @:*ysydom .lo$/ Immolo%s)s o) s%m%l*%)%s $%)h .*.y,%)*-)hym%2 T-2lls/ Th s*l )1DF>1 *d %)s mol2l* .%oloy;4o2/ N*)/ A2*d/ @2%/ 97; 3D97, >
A (*mos B-2ll )mo, )h mos) 2ommo 2h%ldhood 2*2 $hm*l*%* %s dm%2/ I) %s )h (*s)s)-o$% hm* sol%d )mo/os) o(), )h 2h%ldhood +*%*) *%ss % )h V*$/
{46189}A(%2* B%))'s{49035}A(%2* B%))'s
B%))'s lymphom*%ss%o*y s%) B%))'s lymphom*@)*y syKU !oll2)%o
B%))'s lymphom*4*)%) *d pho)om%2o*ph
KU !oll2)%o
B%))'sBy* L
http://www.pathguy.com/sol/15446.jpghttp://www.pathguy.com/sol/15542.jpghttp://www.pathguy.com/sol/00242.jpghttp://www.pathguy.com/sol/46189.jpghttp://www.pathguy.com/sol/49035.jpghttp://www.frtomskids.org/images/burkitts1.jpghttp://www.frtomskids.org/images/burkitts1.jpghttp://www.pathguy.com/lectures/l3.jpghttp://www.pathguy.com/lectures/l3.jpghttp://www.pathguy.com/lectures/l3.jpghttp://www.pathguy.com/lectures/burkitt3.jpghttp://www.pathguy.com/lectures/burkitt3.jpghttp://www.pathguy.com/lectures/burkitt3.jpghttp://www.pathguy.com/bryanlee/l3.htmhttp://www.pathguy.com/bryanlee/l3.htmhttp://www.pathguy.com/sol/15446.jpghttp://www.pathguy.com/sol/15542.jpghttp://www.pathguy.com/sol/00242.jpghttp://www.pathguy.com/sol/46189.jpghttp://www.pathguy.com/sol/49035.jpghttp://www.frtomskids.org/images/burkitts1.jpghttp://www.frtomskids.org/images/burkitts1.jpghttp://www.frtomskids.org/images/burkitts1.jpghttp://www.pathguy.com/lectures/l3.jpghttp://www.pathguy.com/lectures/l3.jpghttp://www.pathguy.com/lectures/l3.jpghttp://www.pathguy.com/lectures/burkitt3.jpghttp://www.pathguy.com/lectures/burkitt3.jpghttp://www.pathguy.com/lectures/burkitt3.jpghttp://www.pathguy.com/bryanlee/l3.htmhttp://www.pathguy.com/bryanlee/l3.htm -
7/24/2019 White Cell Disorders i
50/105
B%))'s
N!I6%%md%* !ommos
B%))'s *() )*spl*)
4%))s.h 4*)holoy !*ss
B%))'s@2)%o
6%%md%* !ommos
B%))'s@m*
6%%md%* !ommos
Th ps)%-B* +%s %s p*) o( )h 2*s, .) o.+%oslyo) )h $hol s)oy/ Ths )mos *lso h*+ * (*mos)*slo2*)%o )h*) pl*2s )h o2o my2 o 2homosom 8d )h 2o)ol o( )h I l*)o o 2homosom 1D/ ? Lsso(), my2 Vo%s )h *pp* 2h*% o >, o l*m.d* o >>/
NOT; 6'+ *l*dy s )h*) m*y lymphom*s %%mmosppssd p*)%)s, .o)h %s%d *d o)s%d )h
!N@, * s)oly l%d )o )h ps)%-B* +%s / *y,.) o) *ll, h*+ B%))-l% h%s)op*)holoy/ No$*d*ys $2*ll )hs 0pos)-)*spl*)*)%o lymphopol%(*)%+d%sods0, *d )hy )d )o ss %( %mmosppss%o2* . d%s2o)%d/
? Mo som *so, )h K*pos% +%s dos') sm )o2*s pos)-)*spl*) lymphopol%(*)%+ d%s*sAm/ / !l%/ 4*)h/ 131; 3>, >
-
7/24/2019 White Cell Disorders i
51/105
.ody m*2oph*s lo*dd $%)h )h%s l%p%d *pp* *s $h%) 0s)*s0**%s) )h .l 0sy0/
Th 0s)*y sy0 *pp**2 o( B%))'s %s * (*+o%) 5*mJs)%o/ s) )o 2o(s yo, )%%.l .ody m*2oph*s*pp* *s s%m%l* 0s)*s0 **%s) )h o)-so-.l-*s-B%))'s0sy0 o( * om*l lymph od/ sp%) 0B% Ro..%s0, )hs)*s o( B%))'s * mo 2osp%2os )h* o)h )%%.l-.ody m*2oph*s .2*s )hy * h*+%ly l*d $%)hl%p%d/
{23620}B%))'s lymphom*, l%p%d dops{46336}B%))'s lymphom*, l%p%d dops{23611}B%))'s lymphom*, ood s)*y sy{46332}B%))'s lymphom*, ood s)*y sy{23641}? B%))'s, m)hyl pyo% )h d 0pyo%oph%l%*0 mly)lls s )h*) )h 2y)opl*sm %s %2h % %.osoms{46326}A(%2* B%))'s, )os%ls
AMRI!AN BURKITT'@, *lmos) *l$*ys B-pos%)%+, %s *lly2*.l $%)h 2hmo)h*py, %( yo 2* ) %) )o )h +%2)%ms/
By 2o)*s), ARI!AN BURKITT'@, * spo*d%2 d%s*s o( yopopl *d )h %mmo2ompom%sd, m*y . B-pos%)%+ oB-*)%+/ I) 2* pod2 m*sss mos) *y$h, *d h*s *$os poos%s/
http://www.pathguy.com/sol/23620.jpghttp://www.pathguy.com/sol/46336.jpghttp://www.pathguy.com/sol/23611.jpghttp://www.pathguy.com/sol/46332.jpghttp://www.pathguy.com/sol/23641.jpghttp://www.pathguy.com/sol/46326.jpghttp://www.pathguy.com/sol/23620.jpghttp://www.pathguy.com/sol/46336.jpghttp://www.pathguy.com/sol/23611.jpghttp://www.pathguy.com/sol/46332.jpghttp://www.pathguy.com/sol/23641.jpghttp://www.pathguy.com/sol/46326.jpg -
7/24/2019 White Cell Disorders i
52/105
"!O@I@ MUNOI@ C @[ZAR" @"NRO L*2) 371; 9DE,>
-
7/24/2019 White Cell Disorders i
53/105
o)h$%s-%)*2)*.l T-2ll 2)*os lymphom*/ @ Blood 1
-
7/24/2019 White Cell Disorders i
54/105
ps)%-B* hmoph*o2y)%2 sydom
")** Ts)sm%
TRATIN T NON-OKIN'@ L"4OA@; Th%s %s U $s/6'+ *l*dy m)%od som o( )h o+l *)s )h*) * $o%/R%)5%m*. 0R%)5*0, * *)%.ody **%s) !>, >; 8E, >
-
7/24/2019 White Cell Disorders i
55/105
? od%'s d%s*s %s * % )h O%)/ Mo som *so,pd%*)%2 od%'s %s 2ommo % )h poo *)%os/
? od%'s d%s*s %s * 2o%:d 2ompl%2*)%o o( AI@, )hohlss )yp%2*l )h* o-od%'s lymphom*s/ No) sp%s%ly,
AI@ p*)%)s $%)h od%'s d%s*s )d )o l*2 lympho2y)s!*2 7; 18E, 1991/
Th m*l%*) 2ll %s )h R-@TRNBR !LL, .) )%l )h l*)s)*s o( )h d%s*s, )h )mo m*sss * 2omposd p%m*%ly o(%(l*mm*)oy 2lls spod% )o )h 2*2/
9ou must reogni@e the&LAI& REED-
TERN7ER% &ELL)
o +.-:. mirons
aross
o multilo1ed
nuleus 3o#ten appears
?1inuleate?4, withlo1es appearing as
mirror images o# one
another
o large, red owl-eye nuleoli,surrounded 1y lear
nulear sap
o pin"-to-
la$ender ytoplasm
o &D+. positi$e
3eBept nodular
lymphoyte
predominant su1type4
{23560}Rd-@). 2ll{20057}Rd-@). 2ll{36398}Rd-@). 2ll, o) &F 2y)oloy
http://www.pathguy.com/sol/23560.jpghttp://www.pathguy.com/sol/20057.jpghttp://www.pathguy.com/sol/36398.jpghttp://www.pathguy.com/sol/23560.jpghttp://www.pathguy.com/sol/20057.jpghttp://www.pathguy.com/sol/36398.jpg -
7/24/2019 White Cell Disorders i
56/105
{36401}Rd-@). 2ll, o) &F 2y)oloy{40423}Rd-@). 2ll, m%)os%s
od%'s
*) l*.lsRom*%* 4*)holoy A)l*s
od%'s $%)h Rd-@). +*%*)s*) l*.ls
Rom*%* 4*)holoy A)l*s
od%'s %s*s 0od%'s *lom*0%s * *2%) m%som/
m* 4*)holoy %%)*l Im* *lly
od%'s d%s*sN%2 Rd-@). 2ll
KU !oll2)%o
od%'s, od
6.4*)h 4ho)o
od%'s, l%+
6.4*)h 4ho)o
Rd-@). 2lls
6.4*)h 4ho)o
Rd-@). 2ll
6.4*)h 4ho)o
od%'s d%s*s, splAMI4
6%%md%* !ommos
od%'s&
6%%md%* !ommos
+y.ody *22p)s )h 19E R" !LA@@IMI!ATION o( od%'sd%s*s $%)h )h 6//O/ mod%(%2*)%o )h*) sp**)d-o) odl*lympho2y) pdom%*)/
http://www.pathguy.com/sol/36401.jpghttp://www.pathguy.com/sol/40423.jpghttp://www.pathologyatlas.ro/hodgkin-lymphoma.phphttp://www.pathologyatlas.ro/hodgkin-lymphoma.phphttp://www.pathologyatlas.ro/hodgkin-lymphoma.phphttp://www.pathologyatlas.ro/reed-sternberg-cell.phphttp://www.pathologyatlas.ro/reed-sternberg-cell.phphttp://www.pathologyatlas.ro/reed-sternberg-cell.phphttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.pathguy.com/lectures/hd.jpghttp://www.pathguy.com/lectures/hd.jpghttp://www.pathguy.com/lectures/hd.jpghttp://www.pathguy.com/lectures/hd.jpghttp://library.med.utah.edu/WebPath/HEMEHTML/HEME043.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME043.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME046.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME046.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME044.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME044.htmlhttp://library.med.utah.edu/WebPath/jpeg5/HEME045.jpghttp://library.med.utah.edu/WebPath/jpeg5/HEME045.jpghttp://commons.wikimedia.org/wiki/Image:Hodgkin's_disease,_spleen.jpghttp://commons.wikimedia.org/wiki/Image:Hodgkin's_disease,_spleen.jpghttp://commons.wikimedia.org/wiki/Image:Hodgkin's_disease,_spleen.jpghttp://commons.wikimedia.org/wiki/Image:Hodgkin_lymphoma_(1)_mixed_cellulary_type.jpghttp://commons.wikimedia.org/wiki/Image:Hodgkin_lymphoma_(1)_mixed_cellulary_type.jpghttp://commons.wikimedia.org/wiki/Image:Hodgkin_lymphoma_(1)_mixed_cellulary_type.jpghttp://www.pathguy.com/sol/36401.jpghttp://www.pathguy.com/sol/40423.jpghttp://www.pathologyatlas.ro/hodgkin-lymphoma.phphttp://www.pathologyatlas.ro/hodgkin-lymphoma.phphttp://www.pathologyatlas.ro/hodgkin-lymphoma.phphttp://www.pathologyatlas.ro/reed-sternberg-cell.phphttp://www.pathologyatlas.ro/reed-sternberg-cell.phphttp://www.pathologyatlas.ro/reed-sternberg-cell.phphttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.pathguy.com/lectures/hd.jpghttp://www.pathguy.com/lectures/hd.jpghttp://www.pathguy.com/lectures/hd.jpghttp://library.med.utah.edu/WebPath/HEMEHTML/HEME043.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME043.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME043.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME046.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME046.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME046.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME044.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME044.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME044.htmlhttp://library.med.utah.edu/WebPath/jpeg5/HEME045.jpghttp://library.med.utah.edu/WebPath/jpeg5/HEME045.jpghttp://library.med.utah.edu/WebPath/jpeg5/HEME045.jpghttp://commons.wikimedia.org/wiki/Image:Hodgkin's_disease,_spleen.jpghttp://commons.wikimedia.org/wiki/Image:Hodgkin's_disease,_spleen.jpghttp://commons.wikimedia.org/wiki/Image:Hodgkin's_disease,_spleen.jpghttp://commons.wikimedia.org/wiki/Image:Hodgkin_lymphoma_(1)_mixed_cellulary_type.jpghttp://commons.wikimedia.org/wiki/Image:Hodgkin_lymphoma_(1)_mixed_cellulary_type.jpghttp://commons.wikimedia.org/wiki/Image:Hodgkin_lymphoma_(1)_mixed_cellulary_type.jpg -
7/24/2019 White Cell Disorders i
57/105
NOULAR L"4O!"T 4ROINANT;
I )h%s %llss, )h * sh)s o( lympho2y)s *d somR@-l% 2lls/ o$+, )h R@ 2lls do') + %mmos)*%l% % o)h (oms o( od%'s )hy * !1E-, !DE, B-
2ll m*s * pos%)%+, *d %)'s po.*.ly 0o) *llyod%'s, m*y. * dyspl*s%*0; old $o Blood 87; >D>8,199F Am/ / 4*)h/ 1D; 81>, 199EF d%(() m)*)%osBlood 1
-
7/24/2019 White Cell Disorders i
58/105
L"4O!"T 4LTION; os)ly 2*2 2lls, l%))l ls/4o.*.ly )h od%'s 2lls h*+ )* *dd%)%o*l m)*)%os/
? Th .*2od m*y . lo)s o( pooly-$o+ 2oll*0d%((s (%.os%s +*%*)0 o Vs) )%2l% 0)%2l* +*%*)0,
$%)h $%ldly **pl*s)%2 2lls/
Th d%s*s o() .) o) *l$*ys ps)s *) l*) s)*/
M) p*)holo%s)s; "o $o') m* )h%s d%*os%s lss)h's * 2o%:*.l Rd-@). 2ll o * p+%osd%*os%s o( od%'s d%s*s/
{23524}lympho2y) dpl)d od%'s d%s*s/ s) pl*% **pl*s)%2/
NOULAR @!LRO@I@; Th%s (*)s l*2* Rd-@).+*%*)s *d * )d2y (o )h ls%o )o .2om 2%ss2ossd .yds 2oll* .*ds/ Th poos%s %s *lly ood/
{23542}odl* s2los% od%'s d%s*s{23545}odl* s2los% od%'s d%s*s{23548}l*2* Rd-@). +*%*)s{23551}l*2* Rd-@). +*%*)
Nodl* s2los% od%'sBy* L Nodl* s2los% od%'s
6.4*)h 4ho)o
Nodl* s2los% od%'s
6.4*)h 4ho)o
L*2* 2lls
6.4*)h 4ho)o
NOT; Th * s.)yps o( *2h 2ommo )yp////
@5 *)%os; Nodl* s2los%s %s * .%) mo 2ommo % $om/ All)h o)h (oms * mo 2ommo % m/
*+% ds2%.d )h%s l*) 2l*ss%(%2*)%o s2hm, I *m *lmos)soy )o h*+ )o *dd )h*) )h poos%s (o *y p*)%2l* 2*s o(
http://www.pathguy.com/sol/23524.jpghttp://www.pathguy.com/sol/23542.jpghttp://www.pathguy.com/sol/23545.jpghttp://www.pathguy.com/sol/23548.jpghttp://www.pathguy.com/sol/23551.jpghttp://www.pathguy.com/bryanlee/nshd.htmhttp://www.pathguy.com/bryanlee/nshd.htmhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME108.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME108.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME109.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME109.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME110.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME110.htmlhttp://www.pathguy.com/sol/23524.jpghttp://www.pathguy.com/sol/23542.jpghttp://www.pathguy.com/sol/23545.jpghttp://www.pathguy.com/sol/23548.jpghttp://www.pathguy.com/sol/23551.jpghttp://www.pathguy.com/bryanlee/nshd.htmhttp://www.pathguy.com/bryanlee/nshd.htmhttp://www.pathguy.com/bryanlee/nshd.htmhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME108.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME108.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME108.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME109.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME109.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME109.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME110.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME110.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME110.html -
7/24/2019 White Cell Disorders i
59/105
od%'s d%s*s %s d)m%d .y s)*, *)h )h* .y )yp/Almos) *ll p*)%)s $%)h s)* I o IIA d%s*s * o$ 2d/ Th%sdops )o *od E>, >/
R-@TRNBR ARIANT@ * *lso m*l%*)/
ONONU!LAR R-@TRNBR-LIK !LL@ 0od%2lls0 h*+ s%l-lo.d 2l% *d o 2lols/ Thy m*y .s % *y +*%*) o( od%'s d%s*s/
? L4 !LL@ ? 0L& 2lls0 h*+ s2*)y 2y)opl*sm, .% o..y2l%, *d sm*ll 2lol%/ Thy * s % lympho2y)pdom%*2 od%'s d%s*s/
LA!UNAR R-@TRNBR !LL@ h*+ *.d*), p*l
2y)opl*sm ? * *)%(*2) o( (om*l% (%5*)%o/ Thy * s %odl* s2los%s od%'s d%s*s/
4OL"LOBULAT R-@TRNBR !LL@ 0pop2o 2lls0loo l% ood Rd-@). 2lls, 52p) )h*) )h 2lol% *')so %mpss%+/ Thy * )yp%2*l o( m%5d 2lll*%)y od%'sd%s*s/
? 4LOOR4I! R-@TRNBR !LL@ * **pl*s)%2+s%os o( )h (*m%l%* (om/ Thy m* p )h .l o( )h )mo
% lympho2y) dpl)%o od%'s d%s*s/
R-@TRNBR !LL RUL@;
6h%l * 2l*ss%2 Rd-@).-l% 2ll m*y *pp* % o)hd%s*ss + 0%(2)%os moo0, %)s ps2 % )h pop.*2od s .lo$ %+s )h d%*os%s o( od%'s d%s*s/
-
7/24/2019 White Cell Disorders i
60/105
"o ms) s * !LA@@I! Rd-@). 2ll .(o m*% )hd%*os%s/
od%'s .%s *s * l*d od o op o( ods/ 6h%l $ doo) )s) yo o s)*%, +y.ody o$s )hs .*s%2s sd (o *
m*Vo%)y o( o-od%'s lymphom*s )oo;
@)* I/// o od op o o*
@)* II/// o s%d o( )h d%*ph*m
@)* III/// .o)h s%ds o( )h d%*ph*m
@)* I///m*o$, o )$o 5)*-lymph*)%2 o*s
0A0 m*s o sys)m%2 symp)oms
0B0 m*s (+, $%h) loss G1
-
7/24/2019 White Cell Disorders i
61/105
%o mys)%s o( md%2%;
1 od%'s p*)%)s o() o)%2 p*% *) s%)s o( d%s*s *() )hyd% *l2ohol/
> od%'s p*)%)s o() h*+ 2)*os *y, + *ly % )h%d%s*s/
INTROU!IN T LUKIA@
Lm%*4*2d m*o$6.4*)h 4ho)o
Lm%*4*2d m*o$6.4*)h 4ho)o
Lm%* C mylodyspl*s%*04*)holoy O)l%s0
N*) 4%2
Lm%* 0$h%) .lood0, d%s2o+d *d *md o( 2os .y%2ho$, %s * %2 )m (o pl*2m) o( )h .o m*o$ .y2*2os .lood 2lls/ Ths s*lly .) o) *l$*ysF m*y *2)lm%*s * %%)%*lly 0*lm%20 * sp%ll% o+ %)o )h.loods)*mF % *y 2*s, 5p2) * 0p*2d m*o$0 52p) % *ly
!LL/
Th s)oy o( poss % )h )*)m) o( )h lm%*s, *ll 2os%dd%2*.l $h I $*s % 2oll, %s ds2%.d % !*2 1137@; 1933,>
-
7/24/2019 White Cell Disorders i
62/105
3AMI4
6%%md%* !ommos
A2) pomylo2y)%2 lm%*ood A ods
KU !oll2)%o
A ods
6.4*)h 4ho)o
O6 TO @4OT A BLA@T; +%$ (om 0%s)oloy0
s2*)y 2y)opl*sm
.% 2ls $%)h mos)ly 2hom*)%
2lol%
M) p*)holo%s)s; "o 2*o) )ll $h)h * %2,d%(()%*)d 0.l*s) 2ll0 %s lympho%d o mylo%d $%)ho)do% sp2%*l s)*%s *dCo 2homosom*l s)d%s o)d*.o+/ "o'll l* .lo$ )h*) A ods * s m*s(o mylo%d d%(()%*)%o/ O( 2os, )od*y yo ms) s%mmoh%s)o2hm%s)y *sy *ppo*2h A2h/ 4*)h/ L*./d/ 13>; D>, >
-
7/24/2019 White Cell Disorders i
63/105
{23842}*2) lympho2y)%2 lm%*, .*%{08734}*2) lm%*, l%+F *s yo $old 5p2), )h lm%* %s .l{08735}*2) lm%*, l%+{08736}*2) lm%*, l%+
A2) Lympho.l*s)%2 Lm%*4%ph*l sm*
KU !oll2)%o
*)h )yp%2*lly sl)s (om hmoh* 2.*l, I, o)h,*dCo %(2)%o )op%*, 2hmo)h*py, *dCo2ompl%2*)%os o( .o m*o$ C s)m 2ll )*spl*)*)%o/
{06269}(*)*l 2.*l hmoh* % lm%*{01735}.*% *d d*, *2) lm%*
Th .%oloy o( )h *2) lm%*s %s +y $ll-s)d%d s)%ll%)s)% L*2) 3D9; 118, 1997/ Th (*2)oy os h*+pmps )o mo+ 2hmo)h*py ds, )2/, )2/
By 2o)*s), !RONI! LUKIA@ 0$ll-d%(()%*)d lm%*s0(*) 2*2 2lls )h*) do m*) mo o lss, *d )h*) h*+ **)*l h%s)oy m*sd % y*s/
L% *2) lm%* p*)%)s, )hs p*)%)s m*y ps) $%)h *2y)op%* po.lm/ O )hy m*y h*+ po.lms (om * h%h $h%)0los)*s%s0 pl% sm*ll +ssls, o m*y o)%2lymph*dop*)hy o o*om*ly, o )h h%h $h%) 2o) m*y. * %2%d)*l (%d% o 0o)% l*.0/
RUL; *o$ 2lls mos) lm%*s, 5)*mdll*yhm*)opo%s%s % )h spl %+ol+ )h d plp/Lymphom*s % )h spl *) l*s) )h B-2ll )yp %+ol+
)h $h%) plp/
RUL; Ay lm%* 2* %+ol+ )h lymph ods *dm* )hm l*, .) )h l*m) %s sldom sosp2)*2l* *s % od%'s o o-od%'s lymphom*/
http://www.pathguy.com/sol/23842.jpghttp://www.pathguy.com/sol/08734.jpghttp://www.pathguy.com/sol/08735.jpghttp://www.pathguy.com/sol/08736.jpghttp://www.pathguy.com/lectures/all.jpghttp://www.pathguy.com/lectures/all.jpghttp://www.pathguy.com/lectures/all.jpghttp://www.pathguy.com/sol/06269.jpghttp://www.pathguy.com/sol/01735.jpghttp://www.pathguy.com/sol/23842.jpghttp://www.pathguy.com/sol/08734.jpghttp://www.pathguy.com/sol/08735.jpghttp://www.pathguy.com/sol/08736.jpghttp://www.pathguy.com/lectures/all.jpghttp://www.pathguy.com/lectures/all.jpghttp://www.pathguy.com/lectures/all.jpghttp://www.pathguy.com/sol/06269.jpghttp://www.pathguy.com/sol/01735.jpg -
7/24/2019 White Cell Disorders i
64/105
RUL; Ay lm%* o lymphom* 2* %+ol+ )h l%+,.) l*m) %s s*lly o) sp2)*2l*/ od%'s *do-od%'s lymphom*s $%ll (%s) *pp* % )h po)*l**s/
L"4OI LUKIA@ 2*ll )h +*%os %ds o( om*llympho2y)s, *d "LOI 0myloos0, o .)), 0*lo2y)%20lm%*s 2*ll * om*l *lo2y)/
"o mm. )h*) "LO!"T@, )h p2sos o(*lo2y)s, * )h mos) 2ommo 2ll % om*l .o m*o$"LO-F h2 )h% *m/
!ll )o+ % )h lm%*s *d )h 2losly-l*)d poly2y)hm%*+* *d p%m*y mylo(%.os%s %s m2h %2*sd, pl*2% )hs
p*)%)s *) %s (o o)/ Th %s %2*ss ()h $h 2*2 2lls *dy% .y )h pod d% )h*py/ Th )hoh)(l o2olo%s) %+spophyl*2)%2 md%2*)%o/
A!UT L"4OBLA@TI! LUKIA 0ALL0F d%*os%s Am/ / !l%/4*)h/ 111; D7, 1999
A2) lympho.l*s)%2 lm%*Bo m*o$
6.4*)h 4ho)o
A2) lympho.l*s)%2 lm%*4%ph*l sm*
6.4*)h 4ho)o
A2) Lympho.l*s)%2 Lm%*T5) *d pho)om%2o*phs/ N%2/
m* 4*)holoy %%)*l Im* *lly
ALL4%))s.h 4*)holoy !*ss
Th%s %s )h (*m%l%* 02h%ldhood lm%*0, $%)h p* * % (o y* old%ds/ Adl) ALL %s lss 2ommo/
? A)ho%)*)%+ m*-+%$ (o p*)holo%s)s 2os%d% *d%*os%s o( lm%* % * 2h%ld; Am/ / !l%/ 4*)h/ 1
-
7/24/2019 White Cell Disorders i
65/105
ALL sms )o s)% *) *dom/ R*d%*)%o 5pos %s * o$ %s(*2)o, o$'s sydom %ds * *) 1E5 )h om*l %s, * p*)%)'s%d)%2*l )$% h*s * >97, 199FL*2) 3D9; 3DD, 1997/
R*2hl !*so's (o)*) %//, (*ls *d %(l*mm*)oyd%s2ss%o o( lm%* % 0@%l) @p%0 %s o$ h%s)oy/ @h $*s%h) *.o) )h d* o( T )o .%ds' s, *d h m*%pl*)%oo( )h d*)* o lm%* %s * m%o .lo) o )h mmoy o( * *)s2%2 $%)/ No.ody's p(2)/ Tod*y, )h's o s%osd%s2ss%o o( )h old *lld l% .)$ %s2)%2%d 5pos*d lm%* ? )h o p*p I 2old (%d (om )h d2*d 1997->; 1D=/// B% 2lls, lo)s o( 2l()s, o() 2lol%F mo 2ommo %*dl)s
L3; 1=/// + .% 2lls, L%J%d B%))'s lymphom*F )8F1D *d+y)h%
{23746}L1{23833}L1, sp2%*l s)*% 2y)opl*sm %s .o${23860}L>{13982}L>, .o m*o$
{23758}L3F o) )h l%p%d{13985}L3
ALL-L1AMI4
6%%md%* !ommos
B%))'s lm%*Bo m*o$KU !oll2)%o
http://www.pathguy.com/sol/23746.jpghttp://www.pathguy.com/sol/23833.jpghttp://www.pathguy.com/sol/23860.jpghttp://www.pathguy.com/sol/13982.jpghttp://www.pathguy.com/sol/23758.jpghttp://www.pathguy.com/sol/13985.jpghttp://commons.wikimedia.org/wiki/Image:ALL-L1.jpghttp://commons.wikimedia.org/wiki/Image:ALL-L1.jpghttp://commons.wikimedia.org/wiki/Image:ALL-L1.jpghttp://www.pathguy.com/lectures/burkitt_l3.jpghttp://www.pathguy.com/lectures/burkitt_l3.jpghttp://www.pathguy.com/lectures/burkitt_l3.jpghttp://www.pathguy.com/sol/23746.jpghttp://www.pathguy.com/sol/23833.jpghttp://www.pathguy.com/sol/23860.jpghttp://www.pathguy.com/sol/13982.jpghttp://www.pathguy.com/sol/23758.jpghttp://www.pathguy.com/sol/13985.jpghttp://commons.wikimedia.org/wiki/Image:ALL-L1.jpghttp://commons.wikimedia.org/wiki/Image:ALL-L1.jpghttp://commons.wikimedia.org/wiki/Image:ALL-L1.jpghttp://www.pathguy.com/lectures/burkitt_l3.jpghttp://www.pathguy.com/lectures/burkitt_l3.jpghttp://www.pathguy.com/lectures/burkitt_l3.jpg -
7/24/2019 White Cell Disorders i
66/105
L3 %s * d%s)%2) )%)y, .) L1 *d L> *') sp2%*lly s(l/ 's * mo-mod %mmopho)yp%2 2l*ss%(%2*)%o;
B-2ll/// 8's oh
42so B *2) lympho.l*s)%2 lm%* C lymphom*
)1>F>1 TLCAL-1
)1;19 4BC>A
)9,>> ABLCB!R 4h%l*dlph%* 2homosom o( 2os
T,11 CLL
42so T *2) lympho.l*s)%2 lm%* C lymphom* ? ()p*)holo%s)s; s)*% (o !7
>/ B%))'s lm%* C lymphom* *ll )h old L3's o h
3/ B%pho)yp%2 *2) lm%*
o (o 2y)o)%2%s)s *d poos)%2*)os;
-
7/24/2019 White Cell Disorders i
67/105
ypd%plo%dy sp2%*lly 0h%h hypd%plo%dy0, GE< 2homosoms, *ll oods)*d*d os, ps) % * l* m%o%)y o( B-2ll ALL's, 2o(s * oodpoos%s/
? M*s o( 2*2po) s2%2 pl*s )* o); I( )h 0%dpd) )h% Cps2)d %s0 2l*%m )h*) 2*2 %s o) 2*sd .y m)*)%os .) .yod%sV2)%o, )h%s 2%os (*2) *.o) lm%* $old o) . )/
Adl)s $%)h ALL * o() 04h%l*dlph%*-pos%)%+0, *d %ds 2* ., )oo? )h l*)) 2o(s * .*d poos%s; N 3D>; 998, >
-
7/24/2019 White Cell Disorders i
68/105
Th%s %s )h 2ommo *2) lm%* o( *dl)s )h %2%d2 %2*ss $%)h *,.) yo *dl)s * o() *((2)d, *d o22*s%o*lly 2h%ld * *((2)d/
Al)hoh mos) 2*ss * %d%op*)h%2, m*y )h%s * o$ )o %2*s %s/Ths %2ld;
o o$'s sydom )%somy >1 -- sp2%*lly AL-7
o )hos (*%l 2homosom sydoms
Bloom's*)*5%* )l*%2)*s%*M*2o%'s *m%* * 2ompl5 )%2 d%sodF ? M*2!Blood 9D; 1, 1999F lm%*s !*2 97; D>E, >
-
7/24/2019 White Cell Disorders i
69/105
p%m*y mylo(%.os%s
poly2y)hm%* +* .*
0ss)%*l0 hmoh*%2 )hom.o2y)hm%*
2ho%2 myloos lm%*
0%d%op*)h%2 *pl*s)%2 *m%*0 s*lly T-2ll *)o%mm
Th 2*2 *%ss o) o( * .*2od o( m)*)d m*o$ 2lls )h*) )yp%2*lly%2ld *lo2y)%2 *d o)h y)ho%d *dCo moo2y) p2sos/ All *l%ly )o sho$ som *.om*l%)%s ? ood )%po((; m**yo2y)s $%)h o-lo.l*)d 2l%/
Th MAB 2l*ss%(%2*)%o A/ I)/ d/ 1
-
7/24/2019 White Cell Disorders i
70/105
1; 0*2) mylo.l*s)%2 lm%* $%)ho) m*)*)%o0F d%(()%*)dmylo.l*s)s $%)h mylopo5%d*sF Vs) m*y. * ($ A ods
>; 0*2) mylo.l*s)%2 lm%* $%)h *lo2y)%2 m*)*)%o0F )h mos)2ommoF som pomylo2y)%2 d%(()%*)%o, m*y. * ($ A odsF
? )8F>1 %s d%s)%2)%+, $%)h (s%o AL1CTO
3; 0*2) pomylo2y)%2 lm%*0F +y *l* pomylo2y)s, o()m*y A ods, I! ? (om *5% II o )h s(*2s )h*) *2)%+*)spl*sm%; N 3DF Blood 8E; >D3, 199EF Blood 9D;39, 1999 ? d%s2o+d .y )h *%l*d !h%s, $ho *))%.)d
)h% s22ss )o l*2 o( l*)%o o( hm* s*2h//// o *y o(o 0)h%2%s)s0 $*) )o 0(s )o s )h%s d*)* $h%2h $*s *2J%d%mmo*lly0
? R)%o%2 *2%d pls -!@M (o )h d%((%2l) )11F17 s.)yp;Blood 9D; 39, 1999/ %*os)%2 s)*% Blood 8; 8>, 199E/
As%2 )%o5%d $*s %)od2d %)o )h )*)m) o( 3 (%s)pos%)%+ po) N 3D> %s .)*-%)(o 2p)o, $h%l 11J>3 %s )h LL mylo%d-lympho%d lm%* F 2ommo % %(*) *d *dl) lm%*s, )hoh
o) 2h%ldhood lm%*s 4o2/ N*)/ A2*d/ @2%/ 88; 183, 1999 *s $ll *s *dl) AL
? LL *lso (oms * (s%o pod2) $%)h N-1 $h%2h %s *dV*2)*d * s2-l% o 2homosom 19 4o2/ N*)/ A2*d/ @2%/ 9D;>E3, 1999 % )11F19 lm%*sF )h%s (s%o pod2) %h%.%)s pE3'spod2) Blood 93; 3>1, 1999/
http://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.microscopyu.com/galleries/pathology/index.html -
7/24/2019 White Cell Disorders i
71/105
? E* %s 0*2) moo.l*s)%2 lm%*0 $%)h +y p%m%)%+-loo%.l*s)s .*% moo2y) m*sF E. %s 0*2) moo2y)%2lm%*0 $%)h * d)d 2ls *d *ls/
; 0*2) y)ho%d lm%*0F (*)s o( d 2ll p2sos
pdom%*)F 0% l%lmo's y)holm%*0 ? () p*)holo%s)s; loo(o d-4A@-pos%)%+ 2hs % )h 2y)opl*sm
7; 0*2) m**yo.l*s)%2 lm%*0F pl*)l) m*sF *2) m*o$(%.os%s ? 4M ((2)F )%2l%F *2) m**yo.l*s)%2 lm%* %s *2h%ldhood lm%* Am/ / !l%/ 4*)h/ 1>>-@; @33, >
-
7/24/2019 White Cell Disorders i
72/105
*d o+5pss%os % mos o)hs/ @)d%s * o$ .% ds%d(o2s% o d%(() )*)m)s dpd% o )hs m)*)%os/ ALso o()m)*)d *)h )h* )*slo2*)d % AL %s NT3A, $h%2h m*s )hpoos%s mo om%os N 33; >D>D, >{16249}.l*s) $%)h A od, >{12344}.l*s) $%)h A od, > o m*y. 3{14010}.l*s) $%)h *) A ods{23776}.l*s)s $%)h lo)s o( *ls, 3{13994}.l*s)s $%)h lo)s o( *ls, 3{16254}.l*s)s $%)h lo)s o( *ls, 3{10109}.l*s)s $%)h lo)s o( *ls, 3
{13997}sm%-moo2y) l% .l*s)s, DF o) %d)d 2ls *d *y 2y)opl*sm{10133}sm%-moo2y) l% .l*s)s, D{13937}o-sp2%(%2 s)*s % D{23800}moo2y)-l% .l*s)s % E{40449}moo2y)-l% .l*s)s % E{40451}moo2y)-l% .l*s)s % E{23803}o-sp2%(%2 s)*s % E{14001}moo2y)-l% .l*s)s % E{13928}o-sp2%(%2 s)*s % E{23949}y)holm%*, / I( yo do') 2o%: )h m*l%*) 2lls *s d-2llp2sos, pl*s 2h2 o) * h%s)oloy .oo/{14007}y)holm%*, {16267}y)holm%*, {23836}y)holm%*, {23806}y)holm%*, {16273}y)holm%*, , 4A@-pos%)%+ 2hs{16274}m**yo2y)%2 .l*s)s, 7/ @ )h pl*)l)s .dd%{23812}m**yo2y)%2 .l*s)s, 7{23821}m**yo2y)%2 .l*s)s, 7
http://www.pathguy.com/sol/12338.jpghttp://www.pathguy.com/sol/16245.jpghttp://www.pathguy.com/sol/13988.jpghttp://www.pathguy.com/sol/23830.jpghttp://www.pathguy.com/sol/13940.jpghttp://www.pathguy.com/sol/23839.jpghttp://www.pathguy.com/sol/23770.jpghttp://www.pathguy.com/sol/13991.jpghttp://www.pathguy.com/sol/16249.jpghttp://www.pathguy.com/sol/12344.jpghttp://www.pathguy.com/sol/14010.jpghttp://www.pathguy.com/sol/23776.jpghttp://www.pathguy.com/sol/13994.jpghttp://www.pathguy.com/sol/16254.jpghttp://www.pathguy.com/sol/10109.jpghttp://www.pathguy.com/sol/13997.jpghttp://www.pathguy.com/sol/10133.jpghttp://www.pathguy.com/sol/13937.jpghttp://www.pathguy.com/sol/23800.jpghttp://www.pathguy.com/sol/40449.jpghttp://www.pathguy.com/sol/40451.jpghttp://www.pathguy.com/sol/23803.jpghttp://www.pathguy.com/sol/14001.jpghttp://www.pathguy.com/sol/13928.jpghttp://www.pathguy.com/sol/23949.jpghttp://www.pathguy.com/sol/14007.jpghttp://www.pathguy.com/sol/16267.jpghttp://www.pathguy.com/sol/23836.jpghttp://www.pathguy.com/sol/23806.jpghttp://www.pathguy.com/sol/16273.jpghttp://www.pathguy.com/sol/16274.jpghttp://www.pathguy.com/sol/23812.jpghttp://www.pathguy.com/sol/23821.jpghttp://www.pathguy.com/sol/12338.jpghttp://www.pathguy.com/sol/16245.jpghttp://www.pathguy.com/sol/13988.jpghttp://www.pathguy.com/sol/23830.jpghttp://www.pathguy.com/sol/13940.jpghttp://www.pathguy.com/sol/23839.jpghttp://www.pathguy.com/sol/23770.jpghttp://www.pathguy.com/sol/13991.jpghttp://www.pathguy.com/sol/16249.jpghttp://www.pathguy.com/sol/12344.jpghttp://www.pathguy.com/sol/14010.jpghttp://www.pathguy.com/sol/23776.jpghttp://www.pathguy.com/sol/13994.jpghttp://www.pathguy.com/sol/16254.jpghttp://www.pathguy.com/sol/10109.jpghttp://www.pathguy.com/sol/13997.jpghttp://www.pathguy.com/sol/10133.jpghttp://www.pathguy.com/sol/13937.jpghttp://www.pathguy.com/sol/23800.jpghttp://www.pathguy.com/sol/40449.jpghttp://www.pathguy.com/sol/40451.jpghttp://www.pathguy.com/sol/23803.jpghttp://www.pathguy.com/sol/14001.jpghttp://www.pathguy.com/sol/13928.jpghttp://www.pathguy.com/sol/23949.jpghttp://www.pathguy.com/sol/14007.jpghttp://www.pathguy.com/sol/16267.jpghttp://www.pathguy.com/sol/23836.jpghttp://www.pathguy.com/sol/23806.jpghttp://www.pathguy.com/sol/16273.jpghttp://www.pathguy.com/sol/16274.jpghttp://www.pathguy.com/sol/23812.jpghttp://www.pathguy.com/sol/23821.jpg -
7/24/2019 White Cell Disorders i
73/105
{23818}m**yo2y)%2 .l*s)s, 4A@-pos%)%+, 7{46340}%%+*l %+ol+m)F )h%s %s 2ommo % D & E
AL4%))s.h 4*)holoy !*ss
>4%))s.h 4*)holoy !*ss
A2) mylo%d lm%*Tom m*'s @%)
D-o6%)h os%oph%ls
6%%md%* !ommos
3AMI4
6%%md%* !ommos
>AMI4
6%%md%* !ommos
>AMI4
6%%md%* !ommos
A ods % .l*s)sAMI4
6%%md%* !ommos
7 m*o$T%y m**yo2y)s6%%md%* !ommos
1AMI4
6%%md%* !ommos
AMI4
6%%md%* !ommos
-
7/24/2019 White Cell Disorders i
75/105
TRAN@INT "LO4ROLIMRATI I@ORR 0)*s%) lm%*0 %ss % )h (%s) $s o( l%( % *od 1D9, >/ R(*2)oy *m%* $%)h %d s%do.l*s)sG1E= o( 2l*)d d 2lls
3/ R(*2)oy *m%* $%)h 52ss .l*s)s E->
-
7/24/2019 White Cell Disorders i
76/105
E/ !ho%2 mylo2y)%2 lm%*
As yo hm*)olo%s) $h*) )h%s *ll m*s/ Th 6old *l)h O*%:*)%op) o) * $, mo-l*.o*) 2l*s%(%2*)%o $%)h 2%)%* % >, >
-
7/24/2019 White Cell Disorders i
77/105
4pos)osly h%h $h%) 2o)s G1
-
7/24/2019 White Cell Disorders i
78/105
%*ss, %s o o( )h *) s22sss o( .%o)2holoyN 3D DE, >, >>E1, >
-
7/24/2019 White Cell Disorders i
79/105
hmoh*%2 0ss)%*l0 )hom.o2y)hm%*
p%m*y mylo(%.os%s
%d%op*)h%2 0*pl*s)%2 *m%*0
2ho%2 myloos lm%*
0A4LA@TI! ANIA0 pd*)s A/ I)/ d/ 13; E3D, >;1D13, >
-
7/24/2019 White Cell Disorders i
80/105
!RONI! L"4O!"TI! LUKIA 0!LL0, 0$ll-d%(()%*)d lympho2y)%2lm%*0F 0)h l%J%d ph*s o( $ll-d%(()%*)d lympho2y)%2 lymphom*0, )2/L*2) 371; 1
-
7/24/2019 White Cell Disorders i
81/105
Th o o$ %s (*2)o %s *)*5%*-)l*%2)*s%* homo:yo)s, +y l%lyh)o:yo)s, *d o) sp%s%ly, )h%s %s o() m)*)d % spo*d%2 2*ssL*2) 3E3; >, 1999/
6 o$ o( o o)h sp2%(%2 %s (*2)os, o) + * h%s)oy o( *d%*)%o/
? !LL h*s * ($ 2ommo )%2 m*s .) )hy *lso o22 % o)h B-2llopl*sms @m%/ m/ 3; 171, 1999/
o dl 13J1D %s 2ommoF o.ody o$s )h dl)d *)%-o2o/
o ) 11F1D, )h .2l1 m)s I, %s *lso 2ommo
o *y 2*ss o( B-2ll !LL h*+ )%somy 1> yo 2* s )h%s % * +*%)y o(o)h B-2ll po.lms/
o A ($ o)hs h*+ )d p 2)ly/ @)*y )d N 3E; >D97, >; DD9, >
-
7/24/2019 White Cell Disorders i
82/105
A ($ p2) o( p*)%)s d+lop * d%((s l*-2ll lymphom*/Th%s %s )h *p%dly-(*)*l RI!TR'@ @"NRO N 3>D; 1>7,1991F pd%spos% (*2)os m*% mys)%os !*2 7; 997,1991/
? Aod 1= o( !LL )m%*)s *s ALL 0.l*s) 2%s%s o( !LL0/
? 4ROL"4O!"TI! LUKIA %s * 2ommo, *ss%++*%*) o( !LL/
!hmo)h*py (o d-s)* !LL; N 33/AIR" !LL LUKIA *yo !l%/ 4o2/ 87; 7, >
Th%s d%s)%2)%+ lm%* %s *md (o )h m*y h*%-l% poV2)%os o %)ss(*2/
I) $*s o( o$ h%s)os%s ? 2o(s% s(*2 m*s )%l %)smol2l* )%2s *d *)%%2 m*s s)*.l%shd %) *s * B-2llopl*sm0 Blood 1EE1, >
-
7/24/2019 White Cell Disorders i
83/105
)mos h*s Vs) . (od % *2h o( D8 h*%y-2ll p*)%)s N 3D; >3F Am/ / !l%/ 4*)h/ 138; 1E3, >/
% )h >-2hloodo5y*dos%, >-!dA o p)os)*)% do5y2o(omy2%,* p% **lo )h*)'s * *)*lly-o22% *)%.%o)%2/ Upd*) !*2 1DD>, >
-
7/24/2019 White Cell Disorders i
84/105
@!ONAR" 4OL"!"TIA %//, )h m*% po.lm %sls$h
((2)%+ *l *)%*l hypo5%*
mphysm*
@lp *p*
T)*loy o( M*llo)
molo.%s $%)h )oo m2h o5y *((%%)y
)2/, )2/
Mo * (%s)-pso s)oy o( %V2)*.l .%o%d
y)hopo%)% *d .%2y2l *2%, %2ld% ho$*)hl)s .*) )h )s)s .y %(s% h *mo)s o(om*l s*l% .y +% mom)s .(o h*+% )h%hm*)o2%)s 2h2d, s @2%/ Am/ >98D; 8>, >, >
-
7/24/2019 White Cell Disorders i
85/105
? y)hopo%)%-dpd) poly2y)hm%*s *l)%)d, pos)-)*spl*) 2* . *ml%o*)d s% A! %h%.%)os, $h%2h %sp::l%; L*2) 3E9; 3, > %s 2)*l )o poly2y)hm%* +*, ss)%*l )hom.o2y)os%s, *dp%m*y mylo(%.os%s, *s %) %s )h )yos% %*s (o )h 2y)o%2p)os )h*) s)%ml*) pod2)%o o( d 2lls poly2y)hm%* +*,m**yo2y)s ss)%*l )hom.o2y)os%s, *d )oph%lsp%m*y mylo(%.os%s, 5pl*%% )h o+l*p *d )*s(om*)%os/Th * *l$*ys *dd%)%o*l m)*)%os % o)h s/ @omml% *llls * m2h mo l%ly )h* o)hs )o m)*) %)o )h*lly .*d *lll N*)/ )/ D1; 38E & DE< & DEE & DD, >
-
7/24/2019 White Cell Disorders i
86/105
O d%s)dd +%s 2* p) I .ld%, hmoh*%2 s)o/+)*lly )hs p*)%)s ) pl*)l) po.lms, )oo, $h%2h dos o) hlp)h .ld% )d2y/
%o mys)y o( md%2%; I)2h% *() )*% * ho) sho$ %s +y
ss)%+ o( 4R/
Th m*%s)*y o( )*)m) (o poly2y)hm%* +* %s l* phl.o)omy, )op )h d 2ll 2o) do$/
Ths p*)%)s' s+%+*l 2+s * *ly *s ood *s om*l (ols/Mo *ll )h o( )h AK> d%s*ss, )h m*Vo %ll %s )h )d2yo( )h d%s*s )o ) %)o *2) myloos lm%*/
Th o2-popl* p*2)%2 o( %+% )hs p*)%)s *d%o*2)%+phosphos sl)d % * *)ly %2*sd *) o( )*s(om*)%o )o
*2) lm%*, )% * o)-so-.*d, *sy-)o-2o)ol d%s*s %)o *l)h*l, )*)*.l o/ L*), )h s*m )h% h*ppd $%)h )%*lso( 2hmo)h*py/
Th )*d%)%o*l 2%)%* (o )h d%*os%s o( 4R;
A1/// I2*sd RB! m*ss GH3 mLCF GH3> mLCF )h m*)h 2oms )o* hm*)o2%) o( E> (o * m*, D (o * $om*
A>/// Nom*l *)%*l 4O>
A3/// @plom*lyB1/// 4l*)l)s *) )h* D
-
7/24/2019 White Cell Disorders i
87/105
(2)%o*lly *2)%+ AK> m)*)%o/ %o 2%)%* * o o( )hs --2h**2)%s)%2 .o m*o$ mopholoy, )oo-lo$ sm y)hopo%)%, *d)h *.%l%)y o( d 2ll 2olo%s )o o$ % )%ss 2l) $%)ho)y)hopo%)%/
? Thom.os%s, )h mos) )o.lsom *sp2) o( )h%s d%s*s, sms )o . m2hlss o( * po.lm %( p*)%)s * s%mply %+ lo$-dos *sp%% N 3E o) .% o o( )h o)h 2o%:*.lmylopol%(*)%+ d%s*ssF 3 som 2lo*l m* s2h *s AK> o oo( )h o)hs o *) l*s) o) 2ho%2 %(l*mm*)%o o 2*2F D T$o o( )h(ollo$%; loy)ho.l*s)%2 sm*F %2*sd sm LF *m%*F
p*lp*.l spl/ Ths * o% )o . d%s2*dd $h )h mol2l*s%*)s * .))-d(%d/
%s)o%2*lly, %o%:% *d%*)%o *d .: 5pos * o$ %s(*2)os/
6 o$ %)'s )mo s%2 )h's * op o( 2ommo )*slo2*)%osFho$+, $h%2h os * ps) dos') %mp*2) poos%s *) l*s) m2h!*2 18>, 4h%l*dlph%* 2homosom %s*.s)/
As % poly2y)hm%* +*, )h 2lls )h*) ) )h .lood * (lly (2)%o*l/Th%s )%m, )h %s o )d2y )o o+-pod2 d 2llsF )oph%ls m*y. sp-*.d*) *d 0l()-sh%()d0 4h%l*dlph%*-2homosom *)%+,o( 2os, o )h m*y . )op%*, o )h 6B! m*y . om*l/4l*)l)s * *((2)d o + %2*sd )%l m*y. +y l*)/
http://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.microscopyu.com/galleries/pathology/index.htmlhttp://www.microscopyu.com/galleries/pathology/index.html -
7/24/2019 White Cell Disorders i
88/105
Th%s %s * d%s*s o( old *dl)s/ 4*)%)s * mos) l%ly )o . )o.ld .y(l% (ll *() )hy'+ *) Vs) * l%))l $hy/
5*m% )h p%ph*l sm*/ Rd 2lls m*d % )h spl )d )o .)*dop-sh*pd o (om o( 0po%%lo2y)0, *d 2l*)d d-2ll
p2sos (om )h spl * mo l%ly )o s2*p %)o )h 2%2l*)%.lood/ Lo2y) *l*l% phosph*)*s %s l%ly )o . h%h/
? Th y* >, $h)h o o) )h l*)) .*s)h )*dm* m)*)%o N 33; 1117, >/
{12302})*dop ds
NOT; Th %mpo)*) )m LUKOR"TROBLA@TI! @AR (s )o
)h ps2 % )h .loods)*m o( yo d 2lls *d %mm*)*lo2y)s/ "o'll s )h%s $h )hy * 0.% pshd o) o( )h%pl*2 o( o%% )oo (*s)0;
.o m*o$ %(%l)*)%o
p%m*y mylo(%.os%s
m)*s)*)%2 2*2%om*
lymphom*
lm%*
.o m*o$ hyppl*s%* C 5)*mdll*y hm*)opo%s%s
s+ hmolys%s, )2/
A() )h%s po2ss h*s . d$*y (o s+*l y*s, )h .o m*o$dos ds (%.os%s/ Lo mys)%os, %) %s o$ 2l* )h*) )h m*o$(%.o.l*s)s * spod% )o o+-pod2)%o o( 4M pl*)l)-d%+d o$)h(*2)o *d ? )*s(om% o$)h (*2)o-.)* pod2d .y *.om*l
m**yo2y)%2 2lls/{13799}mylo(%.os%s, m*o$ 2o .%opsy{24788}mylo(%.os%s, m*o$ 2o .%opsy{13802}mylo(%.os%s, )%2l% s)*%
4*)%)s $%)h 0mylo%d m)*pl*s%* C mylo(%.os%s0 l)%m*)ly d% o(2y)op%* o )*s(om*)%o )o *2) lm%*/ No) sp%s%ly, )hos )h*)
http://www.pathguy.com/sol/12302.jpghttp://www.pathguy.com/sol/13799.jpghttp://www.pathguy.com/sol/24788.jpghttp://www.pathguy.com/sol/13802.jpghttp://www.pathguy.com/sol/12302.jpghttp://www.pathguy.com/sol/13799.jpghttp://www.pathguy.com/sol/24788.jpghttp://www.pathguy.com/sol/13802.jpg -
7/24/2019 White Cell Disorders i
89/105
+)*lly )*s(om %)o *2) lm%* )d )o h*+ * ($ 2%2l*)%.l*s)s *) d%*os%s !*2 11>; >7>, >
-
7/24/2019 White Cell Disorders i
90/105
4l*sm*2y)om* o )%ss .%opsy
G3/< mCdL o *pp* o l*m.d* l%h) 2h*%52)%o G1 mCd*y
B/ %o 2%)%*
1
-
7/24/2019 White Cell Disorders i
91/105
ylom* sll
6.4*)h 4ho)o
ylom* sll
6.4*)h 4ho)o
ylom* m*o$
6.4*)h 4ho)o
ylom* 2lls, s2)%o
6.4*)h 4ho)o
ylom* 2lls, s2)%o
6.4*)h 4ho)o
ylom* 2lls, sm*
6.4*)h 4ho)o
Th moo2lo*l po)% %mmolo.l% o 2h*% pod2d .y * *.om*l2lo o( ml)%pl mylom* 2lls %s 2*lld )h -4ROTIN/
I( )h's * 2ompl) *)%.ody, yo'll s %) o sm po)%l2)ophos%s/
M l%h) 2h*%s m*y . pod2d *lo $%)h, o %s)*d o(, * 2ompl)%mmolo.l%/ Thy p*ss *s%ly )hoh )h loml* .*sm)mm.*, so yo $%ll po.*.ly o) (%d )hm % )h .loods)*m %( )h%dys * $o%/ Is)*d, )hy *22ml*) % )h %, $h )hy *2*lld BN!-ON@ 4ROTIN/ A.o) >C3 o( mylom* p*)%)s pod2B2-os po)%/
http://library.med.utah.edu/WebPath/HEMEHTML/HEME039.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME039.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME085.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME085.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME040.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME040.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME041.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME041.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME070.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME070.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME042.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME042.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME039.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME039.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME039.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME085.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME085.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME085.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME040.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME040.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME040.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME041.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME041.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME041.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME070.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME070.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME070.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME042.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME042.htmlhttp://library.med.utah.edu/WebPath/HEMEHTML/HEME042.html -
7/24/2019 White Cell Disorders i
92/105
L*) o, B2-os po)% pls p )h *l ).ls, *d2o)%.)s )o 0mylom* %dy0, $h%2h $'ll s)dy % )h 0*lp*)holoy0 s2)%o/
"o mm. )h*) pl*sm* 2ll mylom* %s * %mpo)*) 2*s o(
*mylo%dos%s AL, $h%2h dos') hlp *l (2)%o, %)h/
's * .*do$ o )yps o( -po)%s;
EE=///I>E=///IA1=/// I, I, o I moom
18=/// B2-os po)% oly1=/// o -po)%/
A 4ARA4ROTIN %s * *.d*), slss, moo2lo*l po)% % )h
.loods)*m/ All -po)%s * p**po)%sF yo'll m) o)hs/ Lo)s o( *-po)% $%ll pod2 ol*5 (om*)%oF $'ll )*l mo *.o) )h%s %0!l%%2*l 4*)holoy0/
NOT; As * l, pl*sm* 2ll mylom* dos o) m* I p)*ms/6*lds)om's dos )h%s, *d yo $o') s )h )yp%2*l .o 2h*s/
To m* )h d%*os%s, yo $%ll $*) )o (%d * o+*.d*2 G1E= o so osh)s o( pl*sm* 2lls )yp%2*l o $%d-loo% o .o m*o$/
{16554}pl*sm* 2ll mylom*, 2lls
{16556}pl*sm* 2ll mylom*, 2lls{13772}pl*sm* 2ll mylom*, m*o$ *sp%*){27330}pl*sm* 2ll mylom*, m*o$ *sp%*){13775}pl*sm* 2ll mylom*, .o m*o$ s2)%o{10751}? 0*p 2ll0{42054}? 0(l*m 2ll0 *md (o %)s s)*%% pop)%s
Nom*lly, oly *od 3= o( .o m*o$ 2lls * pl*sm* 2lls, .)$h+ )h %s $%dsp*d B-2ll *2)%+*)%o, )h% m. 2* %2*ss.s)*)%*lly/
? M) p*)holo%s)s; I *2)%+ pl*sm*2y)%2 d%sods, pl*sm* 2lls2%2l )h +ssls/ I pl*sm* 2ll mylom*, yo'll po.*.ly (%d pl*sm*2lls 2%2l% (*) 2lls/
4*)%)s * o$ o() ))% *pp*) 2s/ 4**opl*s)%2 po.lms * )h*)s) po.lm % pl*sm* 2ll mylom*/ B *l) (o;
o os)opoos%s
http://www.pathguy.com/sol/16554.jpghttp://www.pathguy.com/sol/16556.jpghttp://www.pathguy.com/sol/13772.jpghttp://www.pathguy.com/sol/27330.jpghttp://www.pathguy.com/sol/13775.jpghttp://www.pathguy.com/sol/10751.jpghttp://www.pathguy.com/sol/42054.jpghttp://www.pathguy.com/sol/16554.jpghttp://www.pathguy.com/sol/16556.jpghttp://www.pathguy.com/sol/13772.jpghttp://www.pathguy.com/sol/27330.jpghttp://www.pathguy.com/sol/13775.jpghttp://www.pathguy.com/sol/10751.jpghttp://www.pathguy.com/sol/42054.jpg -
7/24/2019 White Cell Disorders i
93/105
o p*)holo%2 (*2)s
o hyp2*l2m%* s+*l m2h*%sms
o %(2)%os mylom* 2lls sppss om*l pl*sm* 2lls
o *m%* *d )op%* 2o$d% o) o( om*l 2lls
o %dy (*%l p2%p%)*) *dCo *mylo%d
o ? mylom* op*)hy %(%l)*)%o, 2ompss%o, +%2%s)%
o *mylo%dos%s B 1; 311E, >
-
7/24/2019 White Cell Disorders i
94/105
Thos % 5)*-ossos s%)s 0pl*sm*2y)%2 lymphom*0 m*y o(). s2)d (o 2/
ONO!LONAL AO4AT" OM UN!RTAIN @INIMI!AN!0U@0, )h old 0.% moo2lo*l *mmop*)hy0 *((2)s m*y. 3-E=o( old *dl)s p+*l2 N3ED; 13>, >
-
7/24/2019 White Cell Disorders i
95/105
? !R"OLOBULINIA T"4 I %s * moo2lo*l %mmolo.l%o( m*%*l sol.%l%)y/ o *.o) )h%s % 0!l%%2*l 4*)holoy0
Mollo$ )hs popl p (o d2*ds, *d *od o % (o $%ll )som %d o( s%os *mmop*)hy *yo !l%/ 4o2/ 8; >, 1993/
4OL"!LONAL A!TIATION OM 4LA@A !LL@ 0poly2lo*l *mmop*)hy0 %s* 2ommo (%d% % 2l%%2*l md%2%/ @%)*)%os $o)h mm.%;
o *lly .*d, lo-)m %(2)%os
o lps, hm*)o%d *)h%)%s, o)h 0*)o%mm0
o l%+ d%s*s
o AI@
T LANRAN@ !LL I@TIO!"TO@I@ MAIL" 0L!0, 0%s)%o2y)os%s 0,0d%ssm%*)d h%s)%o2y)os%s0F ? R&M 0d%(()%*)d h%s)%o2y)os%s0 %s * )ypoF +%$ (o2l%%2%*s / 4d/ 1>7; 1, 199EF !*2 8E; >>78, 1999/
A op po.*.ly * 2o)%m o( ls%os )h*) * po.*.ly hos)-)o-oodss)mos o( L*h*s-)yp h%s)%o2y)s, * 2l*ss o( dd%)%2 m*2oph*s/
-
7/24/2019 White Cell Disorders i
96/105
L*h*s 2lls % h*l)h *d d%s*s * 2h**2)%:d .y %)*2lll*BIRB!K RANUL@ 0h%s)%o2y)os%s .od%s0, p)*l*m%* )%s-*2) sh*pd s)2)s o( o$ s%%(%2*2/
? L*%, * l2)% sp2%(%2 )o s)%ml*)d L*h*s 2lls;
Imm%)y 1>; 71, >
-
7/24/2019 White Cell Disorders i
97/105
h%s)%o2y)s h*+ 2o((-.* 2l% *d * *dm%5d $%)h os%oph%ls/ods) )*)m) *lly %s 2*)%+/ Th %s * +*%*) )h*) *((2)s )hls o( smos/
{13688}os%oph%l%2 *lom*
{13691}os%oph%l%2 *lom*{09043}os%oph%l%2 *lom*, , 2o((-.* 2ls l() *d os%oph%l %h)
AN-@!]LLR-!RI@TIAN I@A@ 0ml)%(o2*l %sys)m L!0,*((2)s )h sll .os *d ph*ps -- loo (o d%*.)s %s%p%ds,pop)os%s, ly)%2 sll ls%os, (+, *d *sh/ I)'s %)md%*) .)$ )ho)h )$o % s+%)y/
Ad o) % )h 2l*ss%2 s2hm, .) 2o%:d o$ )h*s )o %mpo+dp*)holoy )2h%Js, !UTANOU@ LANRAN@ !LLI@TIO!"TO@I@, * d%s*s o( %(*)s )h*) o() sl(-2s A2h/
m/ 1D; 1D9, >
-
7/24/2019 White Cell Disorders i
98/105
@4LNOAL" ms) . s.s)*)%*l 8
-
7/24/2019 White Cell Disorders i
99/105
d%)*y spho2y)os%s
molo.%op*)h%s *d .*d )h*l*ssm%*
Imm hmoly)%2 *m%*
Imm )hom.o2y)op%2 pp*
IUNORA!TI "4R4LA@IA
Lps
Rhm*)o%d *)h%)%s
*() V2)%o
@TORA I@A@@ h spl
*2h's +y .%, $*ddd-l5 m*2oph*s
N%m*-4%2's +y .%, (o*my m*2oph*s
)'s
l's
@AR!OIO@I@
A"LOIO@I@ s*o, l*d
"4R@4LNI@ %s s*%d )o . ps) $h * l*d spl ds)oysom*l (omd lm)s o( .lood )oo *d%ly/ Th )h 2*ss yo'll po.*.lys *; 1 2%hos%sF > hm*)o%d *)h%)%s )h s%os 0Ml)y's sydom0,*d 3 *2h's d%s*s/ I)'s *lso o 2*s o( )hom.o2y)op%* % somlm%* *d lymphom* p*)%)s/
{00239}*2h's d%s*s, spl{09864}*2h's d%s*s, spl
{16216}*2h's d%s*s, $*)d-s%l 0$*ddd l50 2ll (om spl
Th oly poo( )h*) hypspl%sm $*s )h po.lm %s )h*) )h .lood2o)s ) .)) $h )h spl %s mo+d/
http://www.pathguy.com/sol/00239.jpghttp://www.pathguy.com/sol/09864.jpghttp://www.pathguy.com/sol/16216.jpghttp://www.pathguy.com/sol/00239.jpghttp://www.pathguy.com/sol/09864.jpghttp://www.pathguy.com/sol/16216.jpg -
7/24/2019 White Cell Disorders i
100/105
B% splMom * 2%ho)%26.4*)h 4ho)o
A!!@@OR" @4LN@ o o mo * ps) som$h % )h *.dom% *.o) >E= o( *)ops%s/ I( yo d * spl2)omy (o * md%2*l d%s*s %//,%mm )hom.o2y)op%2 pp*, hd%)*y spho2y)os%s, yo ms) hop)h*) yo so dos o) o+loo * l* *22ssoy spl/
Rd-@). 2lls
6.4*)h 4ho)o
B% spl@om mylopol%(*)%+ d%sod
6.4*)h 4ho)o
@plom*lyU.** A)l*s o( 4*)holoy
@4TI! @4LN 0osp2%(%2 *2) spl%)%s0 %s )yp%2*l o( s%os .*2)%*l%(2)%os/ Lo*dd $%)h polys *d *.om*lly so(), )h old om) p*)holo%s)sm*d )h 2omp*%so )o 0)om*)o p*s)0, $h%2h %s +y m2h sm.ls/
5*2)ly $hy )h spl .2oms l% )h%s % d*)hs (om sps%s, *d +*y)h% ls, m*%s *s mys)%os *s sps%s %)sl(/ "o'll s po(odloss o( )h B-2lls *d T-hlp 2lls *od )h $h%) plp, *d *pop)os%so( )h dd%)%2 )%2l* 2lls )h*) m*%)*% )h s)2) o( )h splN 3D8; 138, >
-
7/24/2019 White Cell Disorders i
101/105
INMAR!T@ * 2ommo % )h spl, *d m*y sl) (om *)hom.ol%:*)%o)h )$%s)y spl%2 *)y %s )h mos) s+ly *((2)d % )h .ody, l()-s%dddo2*d%)%s, o %(%l)*)%+ d%s*s/
I(*2)s6.4*)h 4ho)o
? N2os%s % * .lood-.lo*)d spl )yp%2*lly, % s%2ls %s l%ly )opod2 %o- *d 2*l2%m-%2h s2*s 2*lld ANA-AN" BOI@/Th 0*)ospl2)om%:d0 spl o( * old s%2l-2ll d%s*s p*)%) %smos)ly 2omposd o( s2h s2*s/
@%2l 2ll d%s*s
A)ospl2)omy6.4*)h 4ho)o
4RIAR" NO4LA@@ o( )h spl * 2ommo/ B% )mos **lmos) + o( *y %mpo)*2/ Ay lymphom* o do)hl%*l opl*sm 2**%s h/ TA@TA@@ )o )h spl * 5p2)d % mos) lm%*s *dod%'s *d o-od%'s lymphom*s, .) 2*2%om*s *d s*2om*s +ysldom o$ % )h spl/
RU4TUR @4LN sl)s (om .lo$s h*d %( yo' h*l)hy, l%h) .lo$s
s((%2 (o )hos $%)h %(2)%os moo2los%sF mm. !4R *s * 2*s B/d/ / 3>>; D8
-
7/24/2019 White Cell Disorders i
102/105
"o mm. )h d%((2 .)$ s2)%os *d sm*s, %h)
? @LI! OM LIM RI6; BLOO !LL@17E` *m%*, %o d(%2%2yF om*l_1371E` lympho2y), om*l_1388` d .lood 2ll, om*l .lood_1391
-
7/24/2019 White Cell Disorders i
103/105
_1D7>>` )%2lo2y)s, om*l_1D7>3` )%2lo2y)s, om*l_1D7>D` d .lood 2ll, *.om*l_1D7>E` d .lood 2ll, *.om*l_1D7>` pl*)l)s, om*l
_1D7>7` pl*)l)s, om*l_1D7>8` poomo.l*s), om*l_1D7>9` poomo.l*s), om*l_1D73` omo.l*s)_1D733` omo.l*s)_1D73D` polymopho2l* lo2y) & ? lympho2y)_1D73E` polymopho2l* lo2y) & ? lympho2y)_1D73` omo.l*s) s%s_1D737` omo.l*s) s%s l*.lld
_1D738` mylo2y), om*l_1D739` mylo2y), om*l_1D7D` mylo2y), .*d (om_1D7D3` mylo2y), .*d (om_1D7DD` mylo2y), om*l_1D7DE` mylo2y), om*l_1D7D` mylo2y), om*l_1D7D7` mylo2y), om*l_1D7D8` mylo2y), om*l_1D7D9` mylo2y), om*l_1D7E` mylo2y) & m**yo2y), om*l_1E193` pl*sm* 2ll, #>3_1E>` polymopho2l* lo2y), om*l_>>3
-
7/24/2019 White Cell Disorders i
104/105
? @LI! OM LIM RI6; L"4OI ORAN@_117ED
http://www.pathguy.com/sol/11750.jpghttp://www.pathguy.com/sol/11751.jpghttp://www.pathguy.com/sol/11753.jpghttp://www.pathguy.com/sol/11797.jpghttp://www.pathguy.com/sol/11805.jpghttp://www.pathguy.com/sol/14753.jpghttp://www.pathguy.com/sol/14754.jpghttp://www.pathguy.com/sol/14755.jpghttp://www.pathguy.com/sol/14756.jpghttp://www.pathguy.com/sol/14757.jpghttp://www.pathguy.com/sol/14758.jpghttp://www.pathguy.com/sol/14759.jpghttp://www.pathguy.com/sol/14760.jpghttp://www.pathguy.com/sol/14761.jpghttp://www.pathguy.com/sol/14762.jpghttp://www.pathguy.com/sol/14763.jpghttp://www.pathguy.com/sol/14764.jpghttp://www.pathguy.com/sol/14765.jpghttp://www.pathguy.com/sol/14766.jpghttp://www.pathguy.com/sol/14767.jpghttp://www.pathguy.com/sol/14768.jpghttp://www.pathguy.com/sol/14769.jpghttp://www.pathguy.com/sol/14770.jpghttp://www.pathguy.com/sol/14771.jpghttp://www.pathguy.com/sol/14772.jpghttp://www.pathguy.com/sol/14773.jpghttp://www.pathguy.com/sol/14774.jpghttp://www.pathguy.com/sol/14775.jpghttp://www.pathguy.com/sol/14776.jpghttp://www.pathguy.com/sol/14777.jpghttp://www.pathguy.com/sol/14778.jpghttp://www.pathguy.com/sol/14779.jpghttp://www.pathguy.com/sol/14780.jpghttp://www.pathguy.com/sol/14781.jpghttp://www.pathguy.com/sol/14782.jpghttp://www.pathguy.com/sol/14783.jpghttp://www.pathguy.com/sol/14784.jpghttp://www.pathguy.com/sol/14785.jpghttp://www.pathguy.com/sol/14786.jpghttp://www.pathguy.com/sol/14787.jpghttp://www.pathguy.com/sol/15189.jpghttp://www.pathguy.com/sol/15190.jpghttp://www.pathguy.com/sol/15191.jpghttp://www.pathguy.com/sol/15192.jpghttp://www.pathguy.com/sol/15194.jpghttp://www.pathguy.com/sol/11750.jpghttp://www.pathguy.com/sol/11751.jpghttp://www.pathguy.com/sol/11753.jpghttp://www.pathguy.com/sol/11797.jpghttp://www.pathguy.com/sol/11805.jpghttp://www.pathguy.com/sol/14753.jpghttp://www.pathguy.com/sol/14754.jpghttp://www.pathguy.com/sol/14755.jpghttp://www.pathguy.com/sol/14756.jpghttp://www.pathguy.com/sol/14757.jpghttp://www.pathguy.com/sol/14758.jpghttp://www.pathguy.com/sol/14759.jpghttp://www.pathguy.com/sol/14760.jpghttp://www.pathguy.com/sol/14761.jpghttp://www.pathguy.com/sol/14762.jpghttp://www.pathguy.com/sol/14763.jpghttp://www.pathguy.com/sol/14764.jpghttp://www.pathguy.com/sol/14765.jpghttp://www.pathguy.com/sol/14766.jpghttp://www.pathguy.com/sol/14767.jpghttp://www.pathguy.com/sol/14768.jpghttp://www.pathguy.com/sol/14769.jpghttp://www.pathguy.com/sol/14770.jpghttp://www.pathguy.com/sol/14771.jpghttp://www.pathguy.com/sol/14772.jpghttp://www.pathguy.com/sol/14773.jpghttp://www.pathguy.com/sol/14774.jpghttp://www.pathguy.com/sol/14775.jpghttp://www.pathguy.com/sol/14776.jpghttp://www.pathguy.com/sol/14777.jpghttp://www.pathguy.com/sol/14778.jpghttp://www.pathguy.com/sol/14779.jpghttp://www.pathguy.com/sol/14780.jpghttp://www.pathguy.com/sol/14781.jpghttp://www.pathguy.com/sol/14782.jpghttp://www.pathguy.com/sol/14783.jpghttp://www.pathguy.com/sol/14784.jpghttp://www.pathguy.com/sol/14785.jpghttp://www.pathguy.com/sol/14786.jpghttp://www.pathguy.com/sol/14787.jpghttp://www.pathguy.com/sol/15189.jpghttp://www.pathguy.com/sol/15190.jpghttp://www.pathguy.com/sol/15191.jpghttp://www.pathguy.com/sol/15192.jpghttp://www.pathguy.com/sol/15194.jpg -
7/24/2019 White Cell Disorders i
105/105
_1E19E` spl, ? d plp *d $h%) plp_1E19` spl, 2)*l *)y_1E197` spl, 2)*l *)y *d m%*l 2)_1E198` spl, )*.2l*_1E199` )hyms, #>E
_1E>7` )os%l p*l*)%
http://www.pathguy.com/sol/15195.jpghttp://www.pathguy.com/sol/15196.jpghttp://www.pathguy.com/sol/15197.jpghttp://www.pathguy.com/sol/15198.jpghttp://www.pathguy.com/sol/15199.jpghttp://www.pathguy.com/sol/15200.jpghttp://www.pathguy.com/sol/15201.jpghttp://www.pathguy.com/sol/15202.jpghttp://www.pathguy.com/sol/15203.jpghttp://www.pathguy.com/sol/15568.jpghttp://www.pathguy.com/sol/15569.jpghttp://www.pathguy.com/sol/15570.jpghttp://www.pathguy.com/sol/15571.jpghttp://www.pathguy.com/sol/15769.jpghttp://www.pathguy.com/sol/15770.jpghttp://www.pathguy.com/sol/20200.jpghttp://www.pathguy.com/sol/20799.jpghttp://www.pathguy.com/sol/20800.jpghttp://www.pathguy.com/sol/20801.jpghttp://www.pathguy.com/sol/20802.jpghttp://www.pathguy.com/sol/20803.jpghttp://www.pathguy.com/sol/20804.jpghttp://www.pathguy.com/sol/20805.jpghttp://www.pathguy.com/sol/20806.jpghttp://www.pathguy.com/sol/20807.jpghttp://www.pathguy.com/sol/20808.jpghttp://www.pathguy.com/sol/20809.jpghttp://www.pathguy.com/sol/20810.jpghttp://www.pathguy.com/sol/20811.jpghttp://www.pathguy.com/sol/20812.jpghttp://www.pathguy.com/sol/20813.jpghttp://www.pathguy.com/sol/20814.jpghttp://www.pathguy.com/sol/20815.jpghttp://www.pathguy.com/sol/20827.jpghttp://www.pathguy.com/sol/15195.jpghttp://www.pathguy.com/sol/15196.jpghttp://www.pathguy.com/sol/15197.jpghttp://www.pathguy.com/sol/15198.jpghttp://www.pathguy.com/sol/15199.jpghttp://www.pathguy.com/sol/15200.jpghttp://www.pathguy.com/sol/15201.jpghttp://www.pathguy.com/sol/15202.jpghttp://www.pathguy.com/sol/15203.jpghttp://www.pathguy.com/sol/15568.jpghttp://www.pathguy.com/sol/15569.jpghttp://www.pathguy.com/sol/15570.jpghttp://www.pathguy.com/sol/15571.jpghttp://www.pathguy.com/sol/15769.jpghttp://www.pathguy.com/sol/15770.jpghttp://www.pathguy.com/sol/20200.jpghttp://www.pathguy.com/sol/20799.jpghttp://www.pathguy.com/sol/20800.jpghttp://www.pathguy.com/sol/20801.jpghttp://www.pathguy.com/sol/20802.jpghttp://www.pathguy.com/sol/20803.jpghttp://www.pathguy.com/sol/20804.jpghttp://www.pathguy.com/sol/20805.jpghttp://www.pathguy.com/sol/20806.jpghttp://www.pathguy.com/sol/20807.jpghttp://www.pathguy.com/sol/20808.jpghttp://www.pathguy.com/sol/20809.jpghttp://www.pathguy.com/sol/20810.jpghttp://www.pathguy.com/sol/20811.jpghttp://www.pathguy.com/sol/20812.jpghttp://www.pathguy.com/sol/20813.jpghttp://www.pathguy.com/sol/20814.jpghttp://www.pathguy.com/sol/20815.jpghttp://www.pathguy.com/sol/20827.jpg